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LONG-TERM NEUROVASCULAR COMPLICATIONS IN CANCER PATIENTS
GENERAL INTRODUCTION
CANCER AND VASCULAR DISEASE
Cancer and vascular diseases are the two leading causes of mortality and morbidity 
worldwide. 1 An autopsy study showed that 15% of patients with cancer had evidence of 
prevalent cerebrovascular disease. 2 This thesis comprises a number of studies that are aimed 
at gaining insight into the relationship between specific forms of cancer and neurovascular 
diseases. The following two cases illustrate neurovascular complications in patients with a 
history of cancer.
Patient 1 a 61 year old man had been treated with bilaterally radiotherapy (70Gy) of the neck 
because of a carcinoma of the oropharynx six years before. Vascular risk factors consisted of 
hypertension, smoking in the past, diabetes, obesity, atrial fibrillation and a positive family history 
for vascular diseases. MRI showed an increased vessel wall thickness of the right carotid artery 
(Figure 1A) and vascular white matter lesions, mostly in the right hemisphere (Figure 1B).
 In patients like these, it is unknown whether primary prevention of cardiovascular disease 
by treatment of classical cardiovascular risk factors is an effective strategy.
Figure 1 
A Proton density weighted MRI showing an increased vessel wall thickness 
 of the right caroti d artery
B MRI of the brain showing vascular white matt er lesions, 
 most prominent in the vascular territory of the right caroti d artery
A B
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GENERAL INTRODUCTION
Patient 2, a 42-year-old women presented with a left sided paresis due to an ischemic stroke 
of the right basal ganglion. Medical history revealed a low-grade astrocytoma in the right 
temporal lobe more than 30 years before for which she had a resection and radiotherapy. 
Furthermore, two years before presentation, patient had been treated for a left sided skull 
base meningioma with a subtotal resection and additional gamma knife radiosurgery. Vascular 
risk factors consisted of hypertension and obesity.
 It is not clear whether only cardiovascular risk factors or also prior resection and radiotherapy 
of the brain tumor caused this ischemic stroke.
Figure 2 
A T2 weighted MRI showing a state aft er a right temporal resecti on of a low-grade glioma (arrow) 
 and a left  sided skull base meningeoma (circle)
B T2 weighted MRI showing an lacunar infarcti on in the right internal capsule (circle)
A B
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LONG-TERM NEUROVASCULAR COMPLICATIONS IN CANCER PATIENTS
The co-occurrence of cancer and vascular disease may be explained by:
1. Chance given the high prevalence of both diseases in the general elderly population.
2. The share of highly prevalent population risk factors, particularly smoking.
3. Direct cancer effects, like cancer-induced hypercoagulable state, nonbacterial 
thrombotic endocarditis or compression of blood vessels by the tumor.
4. Toxicity of anti-cancer treatment either radiotherapy related long-term vasculopathy or 
chemotherapy related hypercoagulability.2,3
RADIOTHERAPY INDUCED NEUROVASCULAR COMPLICATIONS IN HEAD AND NECK CANCER
Since the population of long-term cancer survivors is growing, long-term treatment-related 
complications become more important. In recent years, further insight in and attention for 
these late vascular complications in survivors of specific cancers has increased. The underlying 
pathophysiology of radiotherapy induced carotid vasculopathy is not completely clear. There 
are two lines of thoughts: 1. Acceleration of “common atherosclerosis” and 2. A distinct 
vasculopathic entity starting with injury to the vasa vasorum.4
 Radiotherapy induced carotid artery vasculopathy is a potential long-term complication 
after radiotherapy of the neck, with enhanced risk of ischemic stroke.5-7 The Intima Media 
Thickness of the carotid artery measured by ultrasonography, is a widely used, validated and 
reliable measure of atherosclerosis, and is associated with future cardio- and cerebrovascular 
events.8 Prior retrospective studies showed a larger Intima Media Thickness in the irradiated, 
compared to the non-irradiated carotid artery after a median follow-up period of 8-10 years 
after unilateral radiotherapy of the neck. Increased Intima Media Thickness of the carotid 
artery is associated with an increased risk of ischemic stroke.5,9,10
 The time course of the development of radiotherapy induced vasculopathy, the imaging 
characteristics and the spectrum of clinical implications, like ischemic stroke, vascular cerebral 
white matter lesions and cognitive deficits are unknown in he absence of prospective studies.
CANCER PREVALENCE IN STROKE PATIENTS
The short-term incidence of stroke in patients with active cancer has been studied retrospec-
tively.11 The most frequent types of cancer in a small sample of patients with stroke and cancer 
are lung (30%), brain (9%) and prostate (9%). A recent large study among 327,389 pairs of 
cancer patients and matched controls showed a 3 month increased incidence of stroke in 
patients with lung, pancreatic and colorectal cancers, but not in other types of cancer.12 
Furthermore, an observational study in 1,105 Chinese patients that suffered from an ischemic 
stroke showed that 5.2% had a cancer history. Cancer history was an independent predictor 
of recurrent stroke. 13 No prior study investigated the prevalence and characteristics of cancer 
in a large cohort of patients presenting with ischemic stroke.
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GENERAL INTRODUCTION
PREVENTION OF VASCULAR DISEASE IN HEAD AND NECK CANCER PATIENTS
Patients treated for head and neck cancer harbor an increased risk of ischemic stroke.6 The 
underlying mechanism has not been completely identified, but radiotherapy induced carotid 
vessel wall damage is thought to play an important role. Furthermore, head and neck cancer 
patients typically have an increased burden of vascular risk factors, particularly smoking. 
Although there are several studies pointing to the importance of these long-term vascular 
complications in head and neck cancer survivors, to date prevention guidelines are lacking 
and large prospective follow-up studies are needed.
AIM AND OUTLINE OF THE THESIS
The overall aim of the studies presented in this thesis is to gain more insight in long-term 
neurovascular complications in cancer patients and in particular in those with head and neck 
cancer with the ultimate aim to prevent these complications.
 In Part 1 we describe the long-term neurovascular complications in head and neck cancer 
patients treated with radiotherapy. Chapter 1.1 describes the study protocol. Chapter 1.2 and 
1.3 describe a longitudinal imaging study of carotid Intima Media Thickness in the first 2 and 
7 years after radiotherapy and the incidence of stroke. Chapter 1.4 describes the MRI charac-
teristics of the carotid wall 7 years after radiotherapy. Chapter 1.5 addresses cognitive 
functioning, cognitive complaints, depression and fatigue in patients 7 years after radiotherapy 
of the neck because of head and neck cancer and its relationship with imaging 
characteristics.
 In Part 2 we study cancer prevalence and cancer characteristics in a multicenter cohort 
study consisting of 2,736 patients presenting with ischemic stroke or transient ischemic attack.
 In Part 3 we assess whether in head and neck cancer patients treated with radiotherapy a 
strategy of screening for vascular risk factors and subsequent start of preventive treatment 
could be cost-effective.
511640-L-bw-Wilbers
Processed on: 25-7-2017 PDF page: 12
511640-L-bw-Wilbers
Processed on: 25-7-2017 PDF page: 13
part i
LONG-TERM 
VASCULAR 
AND CEREBRAL 
COMPLICATIONS 
IN HEAD AND 
NECK CANCER
511640-L-bw-Wilbers
Processed on: 25-7-2017 PDF page: 14
511640-L-bw-Wilbers
Processed on: 25-7-2017 PDF page: 15
Joyce Wilbers
Arnoud Kappelle
Roy Kessels
Stefan Steens
Frederick Meijer
Roy Haast
Laura Versteeg
Anil Man Tuladhar
Chris de Korte
Hendrik Hansen
Frank Hoebers
Willem Boogerd
Erik van Werkhoven
Marlies Nowee
Guus Hart
Harry Bartelink
Lucille Dorresteijn
Ewoud van Dijk
STUDY PROTOCOL: PROSPECTIVE COHORT STUDY 
AFTER RADIOTHERAPY FOR HEAD AND NECK CANCER
LONG-TERM CEREBRAL AND 
VASCULAR COMPLICATIONS 
AFTER IRRADIATION OF THE 
NECK IN HEAD AND NECK 
CANCER PATIENTS
a prospective cohort study
study rationale and protocol
1.1
published
BMC Neurology. 2014 Jun 19;14(1):132
511640-L-bw-Wilbers
Processed on: 25-7-2017 PDF page: 16
16
LONG-TERM NEUROVASCULAR COMPLICATIONS IN CANCER PATIENTS
ABSTRACT
BACKGROUND
Successful treatment options for cancer result in more young long-term survivors prone for 
long-term complications. Carotid artery vasculopathy is a potential long-term complication 
after radiotherapy of the neck, resulting in cerebrovascular events and probably deficits in 
cognitive and motor functioning. Better insight into the underlying pathofysiology of 
radiotherapy induced carotid artery vasculopathy is needed for prognostic purposes and to 
develop preventive strategies.
METHODS
The current study is a prospective cohort study on the long-term cerebral and vascular compli-
cations after radiotherapy of the neck, in 103 patients treated for head and neck cancer, 
included in our study database between 2002 and 2008. Baseline protocol (before radiotherapy) 
included screening for cerebrovascular risk factors and intima media thickness measurement 
of carotid arteries by ultrasonography. Follow-up assessment more than 5 years after 
radiotherapy included screening of cerebrovascular risk factors, cerebrovascular events, 
neurological examination with gait and balance tests, extensive neuropsychological 
examination, self-report questionnaires, ultrasonography of the carotid arteries with 
measurement of intima media thickness and elastography, magnetic resonance imaging of 
the brain and magnetic resonance angiography of the carotid arteries.
DISCUSSION
The current study adds to the understanding of the causes and consequences of long-term 
cerebral and vascular changes after radiotherapy of the neck. These data will be helpful to 
develop a protocol for diagnostic and preventive strategies for long-term neurological compli-
cations in future head and neck cancer patients with anticipated radiotherapy treatment.
KEYWORDS
Head and neck cancer, Cerebrovascular disease, Carotid artery, Radiation vasculopathy
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LONG-TERM CEREBRAL AND VASCULAR COMPLICATIONS AFTER IRRADIATION
OF THE NECK IN HEAD AND NECK CANCER PATIENTS
BACKGROUND
Successful treatment options for cancer have resulted in more long-term survivors, prone to 
long-term complications of chemotherapy and radiotherapy (RT). A well-known long-term compli-
cation of RT of the neck is carotid artery vasculopathy, which ultimately can lead to stroke. 5,6
 Apart from acute neurological complications, like a cerebral infarction, evidence from daily 
clinical practice shows more subtle, slowly progressive deficits in cognitive and motor 
functioning. These long-term cerebral and vascular complications in young survivors of cancer 
are a serious potential problem that hamper reintegrating in social functioning and work. The 
longer survival stresses the need for a long-term follow-up study that assesses the long-term 
complications of RT induced carotid artery vasculopathy. To date, no such studies exist to the 
best of our knowledge.
 We hypothesize that RT of the neck accelerates carotid atherosclerosis with secondary 
development of cerebral vascular lesions. These vascular cerebral changes are subsequently 
related to cognitive and motor functioning with a major impact on activities of daily social 
functioning. A better understanding of the underlying pathophysiology of this RT induced 
vasculopathy is needed for prognostic purposes and can be used to develop strategies that 
prevent further progression and thereby reducing the risk of future stroke and neurological 
impairments.
 The current study aims to investigate four questions. The first question focuses on the 
relation between RT and long-term carotid artery-wall changes. We hypothesize that irradiation 
induces premature atherosclerosis which is different from more common atherosclerosis due 
to classic cerebrovascular risk factors. We therefore study the location and composition of 
post-irradiation vessel-wall changes with advanced imaging techniques; plaque and Intima 
Media Thickness (IMT) analysis on ultrasound with innovative vessel-wall elastography and 
magnetic resonance imaging/angiography (MRI)/(MRA). 14,15 The second question examines 
the relation between RT and long-term cerebral vascular changes. In the general population 
the prevalence of silent brain infarcts (SBI) is up to fivefold higher than that of acute stroke. 
16 SBI are related to impaired cognitive functioning, dementia, stroke and gait and balance 
disorders. 17 Carotid artery pathology increases the risk of SBI. 18 To assess this, all study 
patients underwent MRI of the brain to analyze silent brain infarcts and related pathology like 
white-matter lesions and cerebral atrophy.
 The third question addresses the relation between RT and clinical outcome measures (motor 
and cognitive functioning, as well as quality of life; QoL). Silent brain infarcts are associated 
with gait disturbances, decline in cognitive function and increased risk of developing dementia. 
19-21 We performed quantitative gait/balance analysis and an extensive neuropsychological 
assessment in all patients. Finally, we want to study the relation between patient and treatment 
baseline characteristics and the development of vasculopathy, in order to find high risk patients 
that can benefit from preventive strategies.
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LONG-TERM NEUROVASCULAR COMPLICATIONS IN CANCER PATIENTS
METHODS
The current study is a prospective cohort study that aims to investigate the frequency, pathop-
hysiology and long-term outcome of radiotherapy induced vasculopathy. The Medical Ethics 
Review Committee region of Arnhem-Nijmegen approved the study (NL 41008.091.12).
PATIENTS
A prospective cohort study of head and neck cancer patients in two centers of the Netherlands 
(the Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital (NCI/AvL), Amsterdam 
and the Radboud University Medical Center Nijmegen) was initiated.
 At baseline, patients were eligible for inclusion if they received RT of the neck because of 
a T1/T2 (N0M0) laryngeal carcinoma, T1/T2 (N0M0) parotid carcinoma/pleomorphic adenoma, 
T1/2 (N1/2 M0) naso/oro/hypopharynxcarcinoma or non-Hodgkin/Hodgkin lymphoma. 
Originally, the study was designed as an open-label multicentre Prospective Randomized Open 
Blinded Endpoint (PROBE) study to assess the effect of an HMG-coA reductase inhibitor 
(atorvastatine) on carotid IMT in the first 2 years after irradiation of the neck. Because of 
dwindling accrual the study was redesigned to a prospective cohort study. The initial exclusion 
criteria were: a history of cerebrovascular disease, pregnancy or breast-feeding, ongoing 
treatment with an HMG-coA reductase or cytochroom P450 inhibitor, active liver disease or 
> 3 times the upper limit of serum transaminases, 5 times the normal level of creatine 
phosphokinase, serum cholesterol > 7 mmol/L and a life expectancy < 2 years. All patients 
gave written informed consent.
CONTROLS
The IMT measurements will be compared to the baseline measurements and the elastography 
measurements will be compared to an age and sex matched control group of patients who 
had a stroke and at least one of the following cerebrovascular risk factors: hypertension, 
diabetes, smoking, hypercholesterolemia and atrial fibrillation. The cognitive performances 
of all patients will be compared to available normative reference values (adjusted for age and 
education level). Finally, the frequency of silent brain infarctions and white matter lesions will 
be compared to the frequency in patients without RT of the neck, as described in prior 
population based studies. 21,22
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LONG-TERM CEREBRAL AND VASCULAR COMPLICATIONS AFTER IRRADIATION
OF THE NECK IN HEAD AND NECK CANCER PATIENTS
BASELINE
Patients were assessed at baseline (before RT) for height, weight and blood pressure, 
underwent a neurological and laboratory (C-reactive protein) examination and the following 
cerebrovascular risk factors were assessed:
1. Cigarette smoking
2. Hypertension, defined as using antihypertensive medication or blood pressure  
> 130/80 mmHg
3. Diabetes mellitus, defined as using anti-diabetic medication or a non-fasting serum 
glucose >11.1 mmol/L. Medication prescription was checked with the pharmacy 
database
4. Hypercholesterolemia, defined as serum total cholesterol > 6.5 mmol/L
5. Obesity, defined as Body Mass Index (BMI) > 30 kg/m2
CAROTID ULTRASOUND
In patients with laryngeal or hypopharyngeal carcinoma IMT was measured on the Common 
Carotid Artery (CCA), according to the RT-field. In patients with other tumors IMT was measured 
in both the CCA and the Internal Carotid Artery (ICA), also according to the RT- field.
 IMT was measured with a linear array transducer (iU22 Philips NZE172 probe: L17-5, Hewlett 
Packard, Sonos 2000, probe: 7.5/5.5, ALOKA 5000 and G.E Logiq E9). IMT pictures were digitally 
stored on the ultrasound machine or printed in case digital storage was not available. Printed 
images were then scanned at high resolution and interpolated (using Matlab 2010a) to obtain 
the same resolution as the digitally stored images. IMT was automatically measured by one 
blinded investigator (JW), using QLAB (Version 4.2.1, Philips). An edge-detection algorithm 
identified the lumen-intima and the media-adventia interface within a region of interest 
(selected by the operator) over a maximum of 10 mm long segment and calculated the average 
thickness.
FOLLOW-UP > 5 YEARS AFTER RADIOTHERAPY
At follow-up all patients underwent a structured program (Table 1), consisting of assessment 
of demographics and life style, medical history and medication use, fasting laboratory investi-
gation, electrocardiogram (ECG), physical and neurological examination, extensive neuropsy-
chological assessment battery (NPA), carotid artery ultrasound (Intima Media Thickness 
measurement and elastography), MRI/MRA of the brain and carotid arteries, gait and balance 
analysis and self-report questionnaires.
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LONG-TERM NEUROVASCULAR COMPLICATIONS IN CANCER PATIENTS
DEMOGRAPHICS AND LIFE STYLE
Standardized questions on demographics (age at radiotherapy, age at follow-up, sex) were 
administered. Education was classified using seven categories; one being less than primary 
school and seven reflecting an academic degree. Type of work, working situation, marital 
status and living conditions were asked using a structured interview.
MEDICAL HISTORY AND MEDICATION USE
Standard questionnaires about medication use (carbaspirin calcium, oral anticoagulance, 
antihypertensive medication, statin, antidiabetic medication), cerebrovascular risk factors 
(hypertension, hypercholesterolemia, smoking, diabetes, family history, obesity, migraine), 
vascular diseases in the past (stroke, cerebral bleeding, acute myocard infarction, atrial fibril-
lation, angina pectoris, peripheral arterial disease) were asked by one of the investigators 
(JW). If patients had had an ischemic stroke or Transient Ischaemic Attack, detailed medical 
information was collected from their neurologist and reassessed by one neurologist (EvD).
FASTING LABORATORY INVESTIGATION
Fasting blood samples were taken. Analysis included glucose and total cholesterol.
ELECTROCARDIOGRAM (ECG)
An ECG was performed and evaluated with a standardized assessment by an experienced 
cardiologist. Outcome measures were (paroxysmal) atrial fibrillation, left ventrical hypertrophia 
and signs of ischemia (pathologic Q’s, ST depression or elevation).
PHYSICAL AND NEUROLOGICAL EXAMINATION
Height and weight were measured and body mass index (BMI) was calculated. The maximal 
weight circumference was measured in standing position, between the lowest rib and the iliac 
crest, at the end of normal expiration. 23 Blood pressure was measured on the right and left 
side. All patients underwent a standardized neurologic examination by an experienced 
neurologist (JW), consisting of assessment of functioning of cranial nerves, muscle strength 
and cerebellar functions.
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LONG-TERM CEREBRAL AND VASCULAR COMPLICATIONS AFTER IRRADIATION
OF THE NECK IN HEAD AND NECK CANCER PATIENTS
ASSESSMENT OF GAIT AND BALANCE
We used a widely used version of the Tinnetti with 17 items: 9 items for body balance (score 
0-16) and 8 for gait (score 0-12), with a maximum score of 28. 24It grades balance while sitting, 
standing with eyes open and closed, nudging and turning, gait initiation, stride length and 
width and symmetry. Functional mobility was classified by using the widely-used Timed 
Up-and-Go (TUG) test which is a timed test during which the participant is asked to rise from 
a standard armchair, walk 3 m, turn, walk back and sit down again.25 Each participant 
performed the test three times.
NEUROPSYCHOLOGICAL ASSESSMENT
A trained psychologist administered an extensive neuropsychological test battery that covered 
6 cognitive domains; episodic memory, working memory, executive functioning, attention, 
fluency language and speed of information processing. The Mini Mental State Examination 
(MMSE) 26and the Frontal Assessment Battery (FAB)27 were used as a screening of overall 
cognitive function and orientation. Episodic memory was assessed using the five-trial Dutch 
version of the Rey Auditory Verbal Learning Test (RAVLT) in which the ability to acquire and 
retain new verbal information was measured, immediately and after a delay.28 We administered 
the Paper and Pencil Memory Scanning Task29 and the Digit Span test30, both forwards and 
backwards, to assess working memory. Executive functioning was assessed using the Stroop 
Color-Word Task (Stroop interference score; i.e. Part III/mean(Part I and II))31, the Trail Making 
Test (TMT)32 ratio score (part B/part A) and the Brixton Spatial Anticipation Test (Brixton).33,34 
Attention was assessed with the Verbal Series Attention Test (VSAT). REF To evaluate verbal 
fluency two tasks were used. First, a semantic fluency task35 was administered in which 
participants had to name as many animals as possible within 60 seconds followed by as many 
professions within 60 seconds. Second, a letter fluency task36 was used in which as many words 
beginning with a given initial letter (D-A-T) had to be generated within 60 seconds. Speed of 
information processing was evaluated by using three tasks; the Stroop test (mean score Parts 
I and II), the TMT Part A and the Symbol Digit Substitution Task37, which is a modified version 
of the Symbol Digital Modalities Task.
CAROTID ARTERY ULTRASOUND - INTIMA MEDIA THICKNESS MEASUREMENT
The measurement of IMT at follow-up 7 years after RT was exactly the same as described at 
baseline.
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LONG-TERM NEUROVASCULAR COMPLICATIONS IN CANCER PATIENTS
NON-INVASIVE CAROTID ULTRASOUND ELASTOGRAPHY – IMAGING PROTOCOL
Following IMT measurements, the distal CCA and proximal ICA at both sides were examined 
in a longitudinal and transverse imaging plane using a Medison Accuvix V10 ultrasound system 
(Samsung Medison Seoul, Republic of South Korea) equipped with an L5-13 linear array 
transducer (fc = 8.5 MHz). Firstly, longitudinal recordings were acquired. After optimum visuali-
zation of the cross section with the highest amount of luminal narrowing, an imaging mode 
called radial zone mode was turned on, which enabled us to perform angle compounding and 
to store raw ultrasound radiofrequency (RF) data (fs = 61.6 MHz). RF data were acquired at 
three insonification angles (0°, 20° and -20°) for 3 seconds at a frame rate of at least 129 Hz 
(43 Hz/angle). Insonification angles were relative to the unsteered ultrasound beam direction 
and changed sequentially before every new ultrasound image frame. Depending on the heart 
rate, this resulted in the recording of at least two complete cardiac cycles. After the described 
measurement, the systolic and diastolic blood pressures in the brachial artery were determined 
using a sphygmomanometer (Littmann® Classic II S.E.; 3 M, St Paul, MN, USA). The pressure 
values were used to normalize the distensibility and strain results as explained later, since the 
level of strain is not only related to tissue composition but also to the pressure differential 
between the subsequently acquired frames. Above described steps were repeated during 
imaging in the transverse plane. Location of transverse image acquisition was chosen at the 
vessel wall displaying the thickest IMT. The distance between this cross-section and the carotid 
bulb was used as an anatomical reference point. Subsequently, this protocol was repeated for 
the internal carotid artery. The entire measurement series was completed within 30 minutes. 
Raw RF data were subsequently analyzed to determine distensibility and strain using in-house 
written elastography software (MATLAB 2010b, the Mathworks, Natick, MA, USA). Detailed 
description of this can be found in Additional file 1.
MRI PROTOCOL
The MRI studies were performed on a 3 Tesla MR-scanner (Skyra, Siemens Erlangen). The 
scanning protocol included T1, T2 and T2 Fluid Attenuated Inversion Recovery (FLAIR) 
transversal sequences of the brain. The MRI scanning protocol of the carotids included a 3 
dimensional time of flight (TOF), Phase Contrast Angiography (PCA), sagittal oblique T2 of the 
carotid bifurcation, transversal T1, T2 and proton density (PD) sequences. Finally, a maximum 
intensity projection (MIP) TOF and PCA was reconstructed. The complete scanning protocol 
took approximately 60 minutes. All MRI studies will be scored by two blinded experienced 
neuroradiologists (SS and FAM).
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LONG-TERM CEREBRAL AND VASCULAR COMPLICATIONS AFTER IRRADIATION
OF THE NECK IN HEAD AND NECK CANCER PATIENTS
ADDITIONAL SELF-REPORT QUESTIONNAIRES
For the assessment of anxiety and depression we used the Hospital Anxiety and Depression 
Scale (HADS) and the Center for Epidemiologic Studies Depression Scale (CES-D). 38 The 
Checklist on Individual Strength (CIS-20R) was used to assess fatigue. 39 The overall health 
status (quality of life) was assessed with the Short Form 36 Health Survey (SF-36). 40 Patients 
were asked for sleeping problems and their employment status in the period before and the 
period after radiotherapy. Two questionnaires were filled in with a doctor (JW): the assessment 
of Subjective Memory Complaints (SMC) 20 and the Mini International Neuropsychiatric 
Interview (MINI). 41
OUTCOME EVENTS – IMAGING OUTCOMES
Firstly, on ultrasonography, the IMT of the carotid artery 6 years after RT will be compared 
with the IMT at baseline. Furthermore, the strain in the vessel wall and plaque 6 years after 
RT will be measured and compared with a control group. Secondly, on MRI/A of the carotid 
arteries the degree of stenosis, location and when possible composition of vessel wall changes 
(lipids, fibrosis, hemorrhage) will be scored, according to an in house developed protocol.
 All MRIs of the brain will be scored semi-quantitatively by two neuroradiologists separately 
for white-matter lesions (WML), brain atrophy and (silent) brain infarctions using validated 
scales 42-44 and in case of disagreement a consensus meeting will be held.
 Furthermore, total white matter lesion volume will be calculated by a prior published, 
in-house developed, validated technique.45 In short, WML are defined as hyperintensive 
lesions on FLAIR MRI without corresponding cerebrospinal fluid like hypo-intense lesions on 
the T1 weighted image. Gliosis surrounding lacunar and territorial infarcts is not considered 
to be WML. Finally, brain volumetry will be done to measure total white and grey matter 
volumes. Grey and white matter tissue and cerebrospinal fluid probability maps will be 
computed by using a six class segmentation tool in Statistical Parametric Mapping Software 
(http://www.fil.ion.ucl.ac.uk/spm) (SPM 8) on the T1 MPRAGE images. Total grey and white 
matter volumes are calculated by summing all voxel volumes belonging to the tissue class. 
Total brain volume is taken as the sum of total grey and total white matter volume. 
Co-registration parameters of the FLAIR image to the T1 image are computed (SPM8 mutual 
information co-registration) and used to bring both the FLAIR and WML segmentation images 
into the subjects (anatomical) reference frame. Transformed images will visually be checked 
for co-registration errors. Subsequently, the WML segmentations are re-sampled to and 
combined with the white matter maps to yield to a WML map (the intersection of WML and 
white matter) and NAWM map (the complement of WML in white matter) in the T1 reference 
space.
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OUTCOME EVENTS – CLINICAL OUTCOMES
Clinical outcome measures will be: cerebrovascular events, domain scores (mean standardized 
z-scores compared to reference values) of objective cognitive functioning on NPA, subjective 
memory complaints, depressive symptoms, fatigue and gait or balance disturbances.
STATISTICAL ANALYSIS
Analysis of continuous variables will be done with Student’s t test or analysis of (co)variance 
or in case of skewed distributions which cannot be normalized by log transformation corres-
ponding nonparametric tests will be used. Chi-squared test will be used for analysis of 
categorical variables and logistic regression analyses will be used to adjust for potential 
confounding factors.
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RESULTS
103 patients who had sought medical attention at one of the two University Medical Centers 
between 2002 and 2008 fulfilled inclusion and exclusion criteria for our study. The number of 
patients lost to follow-up is reported in Figure 1. 51 patients have been seen for the follow-up 
protocol more than 5 years after RT between November 2012 and November 2013. Another 
14 patients underwent a telephone follow-up. Characteristics of our population at baseline 
and follow-up are reported in Table 2.
511640-L-bw-Wilbers
Processed on: 25-7-2017 PDF page: 26
26
LONG-TERM NEUROVASCULAR COMPLICATIONS IN CANCER PATIENTS
DISCUSSION
The number of cancer survivors is still growing and long-term complications after cancer 
treatment are becoming a serious problem for the society. However, prospective cohort studies 
with a long follow-up period after RT of the neck are scarce. More understanding about the 
underlying pathophysiology of RT induced vasculopathy is needed to develop preventive 
strategies, such as the use of a statin or thrombocyt aggregation inhibitors. These long-term 
complications of RT induced carotid artery vasculopathy are not studied in prior studies, 
because of relatively small patient groups and short follow-up period.
 We therefore performed the current prospective cohort study, to investigate the cerebral 
and vascular long-term complications after RT of the neck. Strong elements of our study are 
the unique population and study design. This cohort is not only the largest, but also has the 
longest follow-up period (more than 5 years after RT). Furthermore, we performed a complete 
assessment with radiological and clinical outcome measurements. We use newly developed 
innovative ultrasonography and MRI techniques, to investigate the underlying pathofysiology 
of RT induced vasculopathy. Also, we examined cognitive function with sensitive neuropsy-
chological tests covering all cognitive domains, rather than just relying on cognitive screens 
aimed at the detection of dementia.
 We feel that the current study helps us in the understanding of the causes and consequences 
of long-term cerebral and vascular changes after RT of the neck. These data will be the source 
to make a protocol for diagnostic and preventive strategies for long term neurological compli-
cations in future HNC patients.
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Figure 1 Flow chart
FU = Follow up US = Ultrasonography MRI/A = Magneti c resonance imaging / Angiography 
NPE = Neuropsychological examinati on
Baseline (n=103)
Radiotherapy
US
(n=50/51)
MRI/A
(n=43/51)
Mobility
(n=47/51)
NPE
(n=44/51)
Questi onaires
(n=65/65)
Site visit FU
(n=51)
Telephone FU
(n=14)
Follow up > 5 years aft er RT
(n=65)
Out of FU (n=38)
 Dead  24
 Too ill  4
 Emigrated  1
 Too far travelling  2
 Other  3
 Unknown  4
FIGURES AND TABLES
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Assessment Baseline Follow up
Demographics
Worksituati on x
Educati on x
Marital status x
Social/living status x
Oncologic diagnose x x
Radiotherapy
Dosis Total (Gy) x x
Dosis per fracti on (Gy) x x
Number of fracti ons x x
Bilateral/unilateral x x
Dose on common caroti d artery x x
Dose on internal caroti d artery x x
Medical History
Cerebrovascular events x x
Cerebrovascular risk factors x x
Cardiovascular events x
Hypertension x x
Hypercholostrolemia x
Smoking x x
Diabetes x
Family history of cerebrovascular disease x
Obesity x
Migraine x
Table 1 Schedule of assessments
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Assessment Baseline Follow up
Medicati on use
Aspirin x
Oral anti coagulance x
Anti hypertensive medicati on x
Stati n x
Anti -diabeti c medicati on x
Physical examinati on
Length and weight x
Waist circumference x
Demographics
Length and weight x
Waist circumference x
Blood pressure x x
BMI x
Neurological examinati on
Cranial nerves x
Muscle strength x
Coordinati on x
Mobility
Time up and Go/Tinetti  x
ECG
Paroxysmal atrial fi brillati on x
Left  ventricle hypertrophia x
Ischemia x
(cont. table 1)
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Assessment Baseline Follow up
Fasti ng laboratory investi gati on
Glucose x
Total cholesterol x
Ultrasonography
IMT x x
Elastography x
Neuropsychological examinati on
Global cogniti ve functi oning x
Minimal Mental State Examinati on (MMSE) x
Frontal Assessment Batt ery (FAB) x
    1. Episodic Memory
Rey Auditory Verbal Learning Test (RAVLT) x
    2. Working memory
Paper and Pencil Memory Scanning Tasks x
Digit Span test x
    3. Executi ve functi oning
Stroop Color-Word Task x
Trail Making Test (TMT) x
Brixton Spati al Anti cipati on Test x
    4. Att enti on
Verbal Series Att enti on Test(VSAT) x
    5. Fluency Language
Lett er fl uency x
Animal fl uency x
    6. Speed informati on processing
TMT A x
Stroop test (mean score Parts I and II) x
Lett er Digity Substi tuti on Task x
(cont. table 1)
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Assessment Baseline Follow up
Questi onnaires
Depressive symptoms
Structured questi onnaire depressive symptoms x
Mini Internati onal Neuropsychiatric Interview (MINI) x
Hospital Anxiety and Depression Scale (HADS) x
Center of Epidemiological Studies Depression scale x
Fati gue
CIS 20 R x
Health related quality of liife
Short form36 x
Others
Structured questi onnaire about sleep disorders x
Subjecti ve memory complaints x
MRI
Brain (T1, T2, FLAIR) x
Caroti d arteries (TOF, PCA, T1, T2, PD) x
(cont. table 1)
511640-L-bw-Wilbers
Processed on: 25-7-2017 PDF page: 32
32
LONG-TERM NEUROVASCULAR COMPLICATIONS IN CANCER PATIENTS
Assessment n = 65
Demographics
Male (%) 60
Age at baseline, years (mean, SD) 54.3 (13.3)
Follow-up post RT, years (mean, SD) 6.7 (1.2)
Age at FU, years (mean, SD) 61.2 (13.4)
Cancer diagnosis (%)
Larynxcarcinoma 45
Paroti dcarcinoma 14
Pleiomorphic paroti d adenoma 15
Nasopharynxcarcinoma 2
Oropharynxcarcinoma 17
Hypopharynxcarcinoma 2
Lymphoma 6
Radiotherapy (%)
Bilateral 63
Unilateral 37
CV Risk Factors at baseline (%)
Smoking
 Current smoker or stopped < 3 years ago 51
 Former smoker or stopped > 3 years ago 23
 Never smoked 25
Hypertension 26
Diabetes mellitus 5
Hypercholesterolemia 9
Obesity 8
Number CV risk factors at Baseline‡ (%)
0 32
1 43
≥2 25
Table 2 Pati ent and treatment related characteristi cs at baseline and FU
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(cont. table 2)
Assessment n = 65
CV Risk factors at FU (%)
Smoking
 Current smoker or stopped < 3 years ago 22
 Former smoker or stopped > 3 years ago 59
 Never smoked 20
Hypertension 70
Diabetes mellitus 11
Hypercholesterolemia 39
Obesity 13
Migraine 11
Family history of CV diseases 20
Vascular diseases in the past (%)
Angina Pectoris 5
Atrial Fibrillati on 11
Acute Myocardial Infarcti on 3
Peripheral arterial Disease 2
Weight circumference, cm (mean, SD) 95.5 (16.6)
Number CV risk factors at FU * (%)
0 9
1 28
≥2 63
‡ Cerebrovascular (CV) risk factors at baseline consists of hypertension diabetes, 
 hypercholostrolemia, overweight and current smoking.
* Cerebrovascular (CV) risk factors at FU consists of hypertension, diabetes, 
 hypercholesterolemia, overweight, current smoking, migraine, family history of 
 vascular disease and Atrial Fibrillati on (AF).
NA = Not answered
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SUPPLEMENTARY
NON-INVASIVE CAROTID ULTRASOUND ELASTOGRAPHY - DATA ANALYSIS
Briefl y, RF data were pre-processed before calculati on of the strain and distensibility values. 
Pre-processing consisted of a correcti on for grati ng lobes (arti facts that arise when performing 
large angle ultrasound beam steering) by band-pass fi ltering 46. Secondly, custom algorithms 
were applied to determine the vessel borders (adventi ti a-media [outer wall] and inti ma-lumen 
[inner wall]), regions of interest, vessel diameter changes over ti me and cardiac cycles 
(between two ti me points corresponding to maximum diameter). The degree of stenosis was 
calculated using the European Caroti d Surgery Trial (ECST) method (1998) aft er defi ning the 
original lumen area.
DISTENSIBILITY
Distensibility for both the inner and outer vessel walls was acquired using the values matching 
the maximum and minimum vessel diameter (i.e. distension) per cardiac cycle:
where dmaximum and dminimum are equal to the values of the maximum and minimum diameter 
respecti vely.
STRAIN
Deformati on of the ti ssue within the pre-defi ned ROIs was esti mated between each sequenti al 
frame during the cardiac cycles. As described by Hansen et al. (2012), axial and lateral (along 
and perpendicular to the transmitt ed ultrasound beam, respecti vely) displacement of the 
ti ssue within the ROI were esti mated for every 12.5 µm in the axial directi on and 200 µm in 
the lateral directi on, per beam steering angle. This was done using course-to-fi ne 2D cross-cor-
relati on displacement esti mati on 47 in four iterati ve steps (see table 1 for parameter setti  ngs). 
Envelope data (Hilbert transformed RF data) were used during the fi rst iterati on step and RF 
data during the following steps.
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No. of iterati ons 4
No. of course-to-fi ne correlati ons 3
Median fi lter 9x9
Window properti es
Size Iterati on 1 Iterati on 2 Iterati on 3 Iterati on 4
Pre-deformati on Axial points 100 50 25 25
Lateral RF-lines 3 3 3 3
Post-deformati on Axial points 150 150 150 150
Lateral RF-lines 9 9 9 9
Overlap Axial 80% 80% 80% 80%
Lateral 67% 67% 67% 67%
Shape Rectangular Free-shape
and 
rectangular
Free-shape
and 
rectangular
Free-shape
and 
rectangular
Course-to-fi ne correlati on Yes Yes Yes No
Aligning No No No Yes
Supplement 1 Parameter setti  ngs displacement analysis
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Axial displacement esti mates of the 0° beam steering angles corresponded to the verti cal 
displacement in the ti ssue, while the axial displacement esti mates from the other two 
beam-steering angles (-20° and 20°) were combined to derive the lateral displacement, using:
where uhor is lateral displacement and uax,ѳ1 and uax,ѳ2 are esti mated axial displacements of 
the beam-steered data at -20° and 20°, respectively. Both the lateral and the axiall 
displacements were cumulated over the cardiac cycle. Next, the radial and circumferenti al 
displacements were derived by combining the axial and lateral displacement components 
with respect to the lumen center. The lumen center was defi ned as the center of the area 
within the inner boundary (inti ma-lumen) of the ROI. Radial and circumferenti al displacements 
were transformed to radial and circumferenti al strain using 2-D least squares esti mators 48. 
In case of longitudinal recordings, axial strain values were acquired by transforming the 0° 
axial displacement estimates. Multiple beam-steered data were used to obtain lateral 
displacements for ROI tracking.
 Ulti mately, distensibility and strain values were normalized for diff erences in blood pressure 
between pati ents using:
where εnorm and εmeas corresponded to normalized and measured strain/distensibility values, 
respecti vely, and psys and pdias were systolic and diastolic blood pressures respecti vely.
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ABSTRACT
BACKGROUND
Carotid artery vasculopathy is a potential long-term complication after radiotherapy of the 
neck, resulting in cerebrovascular events. The underlying pathophysiology is not well 
understood and early markers are lacking. We aimed to study whether radiotherapy of the 
neck is associated with increase in carotid Intima Media Thickness and stroke in the first two 
years after radiotherapy in patients with head and neck cancer.
METHODS
In this prospective cohort study patients treated with radiotherapy of the neck were assessed 
for measurement of Intima Media Thickness before and two years after radiotherapy.Endpoints 
were change in Intima Media Thickness and incidence of first-ever stroke.
RESULTS
Between 2003 and 2008 we included 69 patients (Median age 57 years ( 25-75% quartile 51-64 
years), median dose of radiotherapy 66 Gy (IQR 60-70)) with baseline and follow-up 
measurement of Intima Media thickness. Median Intima Media Thickness at baseline and 
follow-up was 0.60 and 0.62 mm (ratio of geometric means 1.01, 95% CI 0.96-1.08, p=0.63). 
4 out of 69 patients suffered from a stroke. Mean interval from radiotherapy to stroke was 
6.8 months.
CONCLUSIONS
Our study showed no increase of carotid Intima Media Thickness in the first two years after 
radiotherapy of the neck in patients treated for head and neck cancer. This indicates that the 
Intima Media thickness is not a reliable early marker for post irradiation vasculopathy. However, 
a high rate of strokes was observed. A longer follow-up period is needed to find the starting 
point of radiotherapy induced vascular changes.
KEYWORDS
Head and NeckCancer, Stroke, Carotid Artery, Carotid Intima Media Thickness, Radiotherapy
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BACKGROUND
Improving cancer treatment has resulted in more long-term survivors. The counterpart is an 
increase in late cytotoxic effects of both chemo – and radiotherapy (RT). A potential devastating 
long-term side effect of post-irradiation vasculopathy of the carotid arteries is the development 
of ischemic stroke or Transient Ischemic Attack 6,49,50. Although the exact pathophysiology is 
not well understood, the proposed explanations are induction or acceleration of carotid 
atherosclerosis 7. It is unclear whether the composition and location of post irradiation plaques 
and stenosis are different from those of common atherosclerosis due to cardiovascular risk 
factors. The intima media thickness (IMT) of the carotid artery is a valid method to measure 
atherosclerosis and a predictor of future strokes 8 51. Previous retrospective studies showed 
an increase in carotid IMT after a median follow- up period of 8-10 years after neck irradiation 
5,9,10. Moreover, irradiation of the neck was associated with an increased risk of ischemic stroke 
6. Prospective studies with a follow-up periodbetween three months and three years showed 
conflicting results 52-54.
 The current prospective cohort study aimed to evaluate the changes in carotid IMT in the 
first two years after radiotherapy in head and neck cancer (HNC) patients.And whether 
potential change in carotid IMT is associated with an increased incidence of ischemic stroke 
in these patients.
METHODS
A prospective cohort study of HNC patients in two centers of the Netherlands (the Netherlands 
Cancer Institute/Antoni van Leeuwenhoek Hospital (NCI/AvL), Amsterdam and the Radboud 
University Nijmegen Medical Centre (RUNMC), Nijmegen) was initiated.
 Inclusion criterion was cervical RT because ofHead and Neck Cancer (HNC). Originally, the 
study was designed as an open label multicentre Prospective Randomized Open Blinded 
Endpoint (PROBE) study to assess the effect of an HMG-coA reductase inhibitor (atorvastatine) 
on carotid IMT in the first 2 years after irradiation of the neck. Because of dwindling accrual 
the study was redesigned to a prospective cohort study. The initial exclusion criteria were: a 
history of cerebrovascular disease, pregnancy or breast-feeding, ongoing treatment with an 
HMG-coA reductase or cytochroom P450 inhibitor, active liver disease or > 3 times the upper 
limit of serum transaminases, 5 times the normal level of creatine phosphokinase, serum 
cholesterol > 7 mmol/L and a life expectancy < 2 years. All patients gave written informed 
consent. The protocol was approved by the local ethics committees.
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BASELINE AND FOLLOW-UP
Patients were assessed at baseline (before RT) and after 2 years. At every visit height, weight 
and blood pressure were noted, patients underwent a neurological and laboratory (C-reactive 
protein) examination and the following cerebrovascular risk factors were assessed: 1. Cigarette 
smoking. 2. Hypertension, defined as using antihypertensive medication or blood pressure> 
130/80 mmHg. 3. Diabetes mellitus, defined as using anti-diabetic medication or a non-fasting 
serum glucose >11.1 mmol/L. Medication prescription was checked in the pharmacy database. 
4. Hypercholesterolemia, defined as serum total cholesterol > 6.5 mmol/L. 5. Obesity, defined 
as Body Mass Index (BMI) > 30 kg/ m2. If patients had suffered from a ischemic strokeor 
Transient Ischemic Attack, detailed medical information was collected from their neurologist 
and reassessed by one of the investigators (EvD), including assessment of the etiology of 
stroke accor ding to the Modified trial of Org 10172 in Acute Stroke Treatment (TOAST) 
classification 55.
RADIATION THERAPY
Radiotherapy was usually given with a linear accelerator and 4-6 MV photons linear accelerator 
with the patient immobilized using a thermoplastic mask. The target area of the patients 
entered in this study included at least the ipsilateral neck, including part of the carotid artery 
system (e.g. in case of parotid tumors or well lateralized oropharyngeal carcinomas). In other 
patients, both sides of the neck and the vascular system were irradiated (e.g. in case of 
laryngeal or hypopharyngeal carcinoma).
 The radiation treatment was delivered with external beam radiotherapy using either 
standard techniques (parallel opposing beams or wedge-pair techniques) or Intenisity-
Modulated Radiotherapy (IMRT), depending on resources.
 The radiation dose given was typically 30-36 Gy for lymphoma, 50-60 Gy for parotid tumors 
(pleiomorphic adenoma or parotid carcinoma), 60-70 Gy for laryngeal carcinoma and 70 Gy 
for oropharyngeal and hypopharyngeal carcinoma. In the majority of cases, 2 Gy per fraction 
was delivered up to the specified total dose. For patients with lymphoma, parotid tumors or 
T1N0 oropharyngeal carcinoma, a standard once-daily fractionation schedule was used. 
Accelerated fractionation according to the DAHANCA schedule 56 was used for patients with 
T2 or N1 oropharyngeal carcinomas, hypopharyngeal carcinomas and larynx carcinoma 
patients beyond stage T1N0. In patients with T1N0 glottic laryngeal carcinomas the fractio-
nation schedule was 60 Gy in 25 fractions over 5 weeksto the larynx only, using 2 lateral 
opposing fields.
 In every patient separately, the total irradiation dose on the common (CCA) and internal 
carotid artery (ICA) was calculated from the radiation treatment fields.
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CAROTID ULTRASOUND
In patients with laryngeal or hypopharyngeal carcinoma IMT was measured on the CCA, 
according to the RT-field. In patients with other tumors IMT was measured in both the CCA 
and the ICA, also according to the RT- field.
 IMT was measured with a linear array transducer (iU22 Philips NZE172 probe: L17-5, Hewlett 
Packard, Sonos 2000, probe: 7.5/5.5, ALOKA 5000 and G.E Logiq E9), as described earlier 5. 
IMT pictures were digitally stored on the ultrasound machine or printed in case digital storage 
was not available. Printed images were then scanned with high-resolution and interpolated 
(using Matlab 2010a) to obtain the same resolution as the digitally stored images. IMT was 
automatically measured by two blinded investigators (WR/JW), using QLAB (Version 4.2.1, 
Philips). An edge detection algorithm identified the lumen-intima and the media-adventia 
interface within a region of interest (selected by the operator) over a maximum of 10 mm long 
segment and calculated the average thickness.
OUTCOME
The primary endpoint of the study was the change in IMT from baseline to 2 years of follow-up. 
The secondary endpoint was the incidence of ischemic strokeor Transient Ischemic Attack.
STATISTICAL ANALYSES
Log transformation was applied to normalize the distributions of IMT. Log IMT values at 
baseline and 2 years were compared using a paired t-test. To analyze the association between 
risk factors (and treatment arm and RT dose) and IMT, we used ANCOVA, with log IMT at 
2-years as outcome and baseline log IMT as covariate. The results were then back-transformed. 
For a fixed value of baseline IMT, the obtained coefficient is an estimate of the ratio between 
the geometric mean for patients with the particular risk factor compared to the geometric 
mean for patients without the risk factor. Supplementary ANCOVA models with age as an 
additional covariate and ANOVA models with absolute change in log IMT as outcome were 
performed, to check whether the two types of models outcomes gave comparable results. 
Since no major discrepancies were apparent, only the original ANCOVA models were reported. 
The incidence per person year was calculated and compared with the incidence in the 
Oxfordshire Community Stroke Project 1981-1986 57,58 and Continue Morbidity Registration 
Nijmegen47 by assuming a Poisson distribution for the number of events. All analyses were 
performed using SAS (version 9.2, SAS Institute Inc, Cary, NC) and R version 2.15.2 [1].
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RESULTS
STUDY POPULATION
From March 2003 to November 2008 we included 91 patients, of whom 69 were included in 
the analysis. Figure 1 shows the study design and data lost to follow-up. Table 1 shows the 
baseline characteristics. Median dose of RT on measured IMT location was 66 Gy (IQR 60-70).
IMT
Median carotid IMT at baseline was 0.60 mm and at 2 years of follow-up 0.62 mm. (ratio of 
geometric means 1.01, 95% CI 0.96–1.08, p=0.63). Baseline CRP, RT-dose and cerebrovascular 
risk factors (smoking, hypertension, diabetes mellitus, hypercholesterolemia obesity) were 
not associated with change in IMT. Age at diagnosis was significantly associated with IMT at 
follow-up with a multiplicative effect per 10 years of 1.10 (95% CI 1.04–1.16, p=0.001) (Table 
2). IMT increase from baseline to 2 years of follow-up was not different between the patients 
treated with or without atorvastatin (- 0.04 mm versus 0.01mm, p-value 0.96).
CEREBROVASCULAR ACCIDENTS
From baseline to two years of follow-up 4 out of 69 patients suffered from a ischemic stroke 
(n=2) or Transient Ischemic Attack (n=2). Mean age at stroke was 69 years. Mean RT-stroke 
interval was 6.8 months (Table 3) In 2 patients the vascular territory matched with the high 
RT portal field.
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DISCUSSION
Our study showed no increase in carotid IMT in the first two years after neck irradiation.This 
result is in accordance with prior retrospective studies that demonstrated an increase in carotid 
IMT after a median follow up of 8-10 years after irradiation 5,9,10. However, the starting point 
of this increase in carotid wall thickness was unclear. These prior retrospective studies lacked 
baseline IMT measurements, hence other factors could be the cause of the IMT increase.
 A recent review pointed to the problem that the long latent interval from treatment to the 
development of clinical complications makes investigation of this process difficult 7. The 
strength of our study was the prospective design and the precise computer assisted 
measurement of the IMT. By our knowledge, this is the largest and longest prospective post 
neck irradiation cohort study with baseline and follow-up IMT measurements. Although the 
current study was done in an heterogeneous group of patients with different malignancies of 
the head and neck region, the RT treatment protocols were homogeneous and because this, 
our results have high external validity. Information bias was minimalized, because baseline 
and follow-up IMT were separately assessed by one investigator, unaware which one was 
baseline or follow-up.
 Our study contradicts the conflicting results of prior small prospective studies, with only a 
short follow-up period after radiotherapy.The first described prospective study of a small group 
of 36 Head and Neck Cancer (HNC) patients, found a significant increase in the IMT of both 
the left (0.67 vs 0.84 mm) and right ( 0.70 vs 0.87mm) carotid artery 1 year after irradiation, 
with a further increase in a subgroup of 12 patients 2 years after RT 52. Characteristics (RT 
dosage or cerebrovascular risk factors) of this subgroup were not described. Average RT dose 
was 60 Gy and therefore comparable with our study. However, compared to our data, the IMT 
was not measured digitally, the mean age of the study population was 3.5 years higher and 
possible confounding factors were not taken into account. Another prospective study of 19 
patients treated for HNC with a mean age of 55 years and a dose of 66 Gy, showed no significant 
increase in IMT from baseline to only 6 months after RT 53. A larger prospective study of 96 
patients with a mean age of 59.3 year, treated for Non Hodgkin Lymphoma (n=54) or Hodgkin 
Disease (n=42) with chemotherapy and external beam RT of a mantle field (total dose of upper 
body 36-40 Gy) showed a significant decrease in IMT 3 years after RT when compared to the 
first year after RT 54. However, baseline IMT and dosage of RT on the IMT location were lacking 
and 21 % of patients were lost to follow up, which was a potential selection bias. The temporary 
increase of IMT in the first year after RT was attributed to edema, but regression towards the 
mean could be another explanation. Taken these results together, we think IMT is not a reliable 
early marker for RT induced carotid artery vasculopathy.
511640-L-bw-Wilbers
Processed on: 25-7-2017 PDF page: 46
46
LONG-TERM NEUROVASCULAR COMPLICATIONS IN CANCER PATIENTS
 Limitations of the current study were a potential underestimation of IMT change, firstly 
because of regression dilution bias as a consequence of two blinded separated measurements 
instead of a single measurement of change in IMT. Secondly, there could be selective follow-up 
and we included patients with a relative favorable vascular risk profile, because patients with 
former Transient Ischemic Attack/stroke and those who were on HMG-co A reductase inhibitors 
were excluded.
 The underlying pathophysiology of RT induced vasculopathy needs to be further elucidated, 
but RT typically damages all the three layers of the vessel wall 4. Histopathological studies 
showed, that RT induced vasculopathy differed from the common atherosclerosis in a trend 
towards greater lipid and calcium content of the plaques, more thickening and fibrotic changes 
of the adventitia and more pronounced thinning of the media 59. Inflammation plays a central 
role in the inception and progression of atherosclerosis and plasma CRP is a systemic biomarker 
associated with local atherosclerosis and a predictor of future cardiovascular events 60.We did 
not find a correlation between CRP before and after radiotherapy or between baseline CRP 
and change in IMT. However, the change in CRP could be too small and the power of the study 
insufficient to rule out such a relationship.
 The annual incidence rate of first ever ischemic stroke or Transient Ischemic Attack in our 
cohort was both 15/1000 patient years. These are relative high numbers compared to 
community based studies, like the Oxfordshire community stroke project, in which the rates 
are respectively 1.60/1000 and 0.35/1000 57,58. However, the absolute low number of incident 
cases in our cohort and the indirect comparison withhold us from further speculation. The 
low absolute number of strokes in our cohort lack statistical power for further analysis. The 
mean time between RT and ischemic event (6.8 months) is very short and there is no relation 
between IMT increase. Possible other explanations for this high incidence rate of stroke (when 
compared to the community) are: a merely high incidence in the HNC patients, related to 
cerebrovascular risk factors, a hypercoagulable state in oncologic patientsor an acute RT 
induced temporarily inflammatory reaction instead of IMT increase.
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 It is known that neck irradiation is associated with at least a doubled relative risk of ischemic 
stroke or Transient Ischemic Attack on the long term (4 to 18 years after RT) 4. Two mechanisms 
of RT induced vasculopathy should be distinguished; besides the chronic stenotic form of 
disease which may take several years to develop, acute vascular complications as a consequence 
of periarterial inflammation and plaque rupture can occur within a short follow-up period 
after radiotherapy 61. The fact that two of the four patients that suffered from a stroke had 
symptoms compatible with a vascular territory outside the high portal RT field, implicates that 
this study population has already a high chance to develop a stroke, probably because of not 
RT associated causes, like an hypercoagulable state as a consequence of a paraneoplastic 
effect 62 or lifestyle factors. Increased IMT is associated with vascular risk factors 8,63. In a 
retrospective cohort study among 5 years survivors of Hodgkin disease, hypertension, diabetes 
and hypercholesterolemia were associated with the occurrence of ischemic stroke, whereas 
smoking and overweight were not 50. We found no correlation between baseline cerebro-
vascular risk factors and change in IMT. However, the most frequent baseline risk factor was 
smoking and most patients stopped smoking for a period during and after RT.
 In conclusion, the current study showed no increase in carotid IMT within the first two 
years after neck irradiation. These results suggest that carotid IMT is not a reliable early marker 
of RT induced carotid vasculopathy. Since IMT can increase during a longer time interval, we 
will increase the follow-up period of the current cohort.
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FIGURES AND TABLES
Figure 1 Study design
IMT = Inti ma Media Thickness RT = Radiotherapy
T1/2 larynxcarcinoma
Hypopharynxcarcinoma
Oropharynxcarcinoma
Hodgkin / non-Hodgkin
Lymphoma
T1/2 paroti d carcinoma
Pleomorphic paroti d adenoma
Tumorresecti on
IMT baseline
(n=91)
Radiotherapy
IMT 2 aft er RT
(n=69)
Lost to follow up (n=14):
 Died 9
 Emigrated 1
 Too ill 1
 Unknown reason 3
Missing IMT measurement
(n=8)
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N=91 n=91
Gender (Male) 61 (67%)
Age (years)* 57 (51–64)
Tumor locati on
Larynx 46 (51%)
Paroti d 22 (24%)
Oropharynx 16 (18%)
Hypopharynx 4 (4%)
Lymphoma 3 (3%)
RT cervical lymph nodes 43 (47%)
Dose on IMT locati on
Low Dose (30– 55 Gy) 17 (19%)
Middle Dose (55–68 Gy) 38 (42%)
High Dose (68–70 Gy) 36 (40%)
CV Risk factors
Smoking history
Never smoked 22 (24%)
Former smoker (stopped > 3 years ago) 18 (20%)
Current smoker or stopped < 3 years ago 48 (53%)
NA 3 (3%)
Hypertension 29 (32%)
Diabetes mellitus 5 (5%)
Hypercholesterolemia 8 (15%)
Obesity 3 (6%)
Number CV risk factors
0 24 (26%)
1 37 (41%)
≥2 30 (33%)
Table 1 Pati ent baseline and treatment characteristi cs
Data are expressed as absolute numbers of patients (%), unless otherwise indicated.
Cerebrovascular (CV) risk factors at FU consists of current smoking, hypertension, 
diabetes mellitus, hypercholesterolemia and obesity.
* Age expressed as median (25-75% quantile)
NA = Not answered
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Multi plicati ve Eﬀ ect* (95% CI) p-value
Baseline characteristi cs
Current smoking 1.03 (0.91-1.17) 0.67
Hypercholesterolemia 0.98 (0.82-1.17) 0.80
Obesity 1.00 (0.72-1.41) 0.98
Hypertension 1.05 (0.91-1.21) 0.53
Diabetes Mellitus 1.06 (0.80-1.40) 0.71
Any cerebrovascular risk factor† 1.09 (0.95-1.26) 0.22
Age (per ten years) 1.10 (1.04-1.16) 0.0012
Log CRP value (per standard deviati on) 1.01 (0.94–1.09) 0.85
Tumor type 0.16‡
Paroti d carcinoma vs. larynxcarcinoma 0.76 (0.61-0.95)
Pleomorphic paroti d adenoma vs. larynxcarcinoma 0.88 (0.72-1.08)
Oropharynxcarcinoma vs. larynxcarcinoma 0.90 (0.75-1.08)
Hypopharynxcarcinoma vs. larynxcarcinoma 1.13 (0.82-1.56)
Hodgkin lymphoma vs. larynxcarcinoma 1.02 (0.78-1.34)
Radiotherapy treatment 0.89‡
RT dose 55–68 Gy vs. 30–55 Gy 1.02 (0.85-1.22)
RT dose 68–71 Gy vs. 30–55 Gy 1.04 (0.87-1.25)
Table 2 Esti mated multi plicati ve eff ect of baseline characteristi cs and RT dosage 
 on two year IMT value, adjusted for baseline IMT
RT = Radiotherapy  IMT = Intima Media Thickness
* The coeffi  cient is an esti mate of the rati o between the geometric mean for pati ents with the 
 parti cular risk factor compared to the geometric mean for pati ents without the risk factor.
† Cerebrovascular risk factors consits of current smoking, hypertension, diabetes mellitus, 
 hypercholesterolemia and obesity.
‡ Multi ple degrees of freedom test
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ABSTRACT
BACKGROUND AND PURPOSE
Carotid artery vasculopathy is a long-term complication of radiotherapy (RT) of the neck. We 
investigated the change in carotid Intima Media Thickness (IMT) and the incidence of ischemic 
stroke in the first 7 years after radiotherapy (RT) of the neck.
MATERIALS AND METHODS
A multicentre prospective cohort study among patients treated for Head and Neck Cancer 
(HNC) assessed carotid IMT at baseline (before RT) and after a median of 7 years follow-up. 
We also screened for cerebrovascular risk factors and events.
RESULTS
48 patients underwent IMT measurement at baseline and follow-up (median age 61 years, 
range 29-87). Mean IMT of the irradiated common carotid arteries was 0.64 mm at baseline 
and 0.74 mm at follow-up (p=0.002). Mean delta IMT in the irradiated and non-irradiated 
common carotid arteries were 0.11 and 0.02 mm (p=0.03). Incidence rate of stroke in our 
cohort, compared to the Dutch population was 8.9 versus 1.5 per 1.000 person years.
CONCLUSIONS
IMT in irradiated carotid arteries was significantly increased in the first 7 years after RT. The 
incidence rate of stroke was six fold increased. Patients treated with RT for HNC have sustained 
risk for developing atherosclerosis of the carotid arteries and future stroke.
KEYWORDS
Head and neck cancer, Intima Media Thickness, cerebrovascular disease, carotid artery, 
radiation vasculopathy
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INTRODUCTION
Cancer and cardiovascular disease are the leading causes of mortality and morbidity 
worldwide 1. Successful treatment options for cancer result in more long-term survivors prone 
to long-term complications. Radiotherapy (RT) induced carotid artery vasculopathy is a 
potential long-term complication after RT of the neck, with enhanced risk of ischemic stroke 
5-7. To find diagnostic and preventive strategies, more insight in the underlying pathophysiology 
is needed. The current study investigated the characteristics of these long-term vascular 
changes by measurement of the Intima Media Thickness (IMT) in an unique cohort of patients 
treated for head and neck cancer (HNC) with 7 years follow-up.
 The IMT of the carotid artery is a widely used, validated and reliable measure of atheros-
clerosis, and is associated with future cardio-and cerebrovascular events 8. Prior retrospective 
studies showed a larger IMT in the irradiated, compared to the non-irradiated carotid artery 
after a median follow-up period of 8-10 years after unilateral RT of the neck. Increased IMT 
was associated with an increased risk of ischemic stroke 5,9,10. Prior small prospective studies 
with a limited follow-up time between three months and three years showed conflicting results 
52,54,64. In the current study cohort, we previously showed no increase in carotid IMT in the 
first two years after RT. 65 In this long-term prospective follow-up study we investigated the 
change in carotid IMT and the incidence of IS in the first 7 years after RT.
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METHODS
STUDY DESIGN AND PATIENTS
This study was part of a prospective multicentre cohort study, designed to investigate the 
long-term vascular and cerebral complications after RT of the neck. The detailed study protocol 
was described earlier.66 In short, study subjects were recruited in two university medical 
centers in the Netherlands (the Netherlands Cancer Institute/Antoni van Leeuwenhoek 
Hospital (NKI/AvL) and the Radboud University Medical Center). At baseline, patients were 
eligible for inclusion if they received RT of the neck because of a T1/T2 (N0M0) laryngeal 
carcinoma, T1/T2 (N0M0) parotid carcinoma / pleomorphic adenoma, T1/2 (N1/2M0) naso/
oro/hypopharynxcarcinoma or non-Hodgkin/Hodgkin lymphoma. (Table 1). The Medical Ethics 
Review Committee region of Arnhem-Nijmegen approved the study (NL 41008.091.12). 
Originally, the study was designed as an open-label multicentre Prospective Randomized Open 
Blinded Endpoint (PROBE) study to assess the effect of an HMG-coA reductase inhibitor 
(atorvastatin) on carotid IMT in the first years after irradiation of the neck. Because of dwindling 
accrual the study was redesigned to a prospective cohort study. Among the initial exclusion 
criteria was history of cerebrovascular disease. All patients gave written informed consent.
 Patients were assessed at baseline (before RT) for height, weight and blood pressure, 
underwent a neurological examination, and the following cerebrovascular risk factors were 
assessed: 1. Cigarette smoking. 2. Hypertension, defined as using antihypertensive medication 
or blood pressure > 130/80 mmHg. 3. Diabetes mellitus, defined as using anti-diabetic 
medication or a non-fasting serum glucose >11.1 mmol/L. Medication prescription was checked 
in the pharmacy database. 4. Hypercholesterolemia, defined as serum total cholesterol 
> 6.5 mmol/L. 5. Obesity, defined as Body Mass Index (BMI) > 30 kg/m2.
 If patients reported an incident of IS or TIA at follow-up detailed medical information was 
collected from their neurologist and reassessed by one vascular neurologist (EvD). From the 
patients out of follow-up the reason, cause of death and occurrence of stroke was checked at 
the general practitioner, the patient or family members.
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RADIATION THERAPY
Radiotherapy was usually given with a linear accelerator and 4-6 MV photons linear accelerator 
with the patient immobilized using a thermoplastic mask. The target area of the patients 
entered in this study included at least the ipsilateral neck, including part of the carotid artery 
system (e.g. in case of parotid tumors or well lateralized oropharyngeal carcinomas). In other 
patients, both sides of the neck and the vascular system were irradiated (e.g. in case of 
laryngeal or hypopharyngeal carcinoma).
 The radiation treatment was delivered with external beam radiotherapy using either 
standard techniques (parallel opposing beams or wedge-pair techniques) or Intenisity-
Modulated Radiotherapy (IMRT), depending on resources.
 The radiation dose given was typically 30-36 Gy for lymphoma, 50-60 Gy for parotid tumors 
(pleiomorphic adenoma or parotid carcinoma), 60-70 Gy for laryngeal carcinoma and 70 Gy 
for oropharyngeal and hypopharyngeal carcinoma. In the majority of cases, 2 Gy per fraction 
was delivered up to the specified total dose. For patients with lymphoma, parotid tumors or 
T1N0 oropharyngeal carcinoma, a standard once-daily fractionation schedule was used. 
Accelerated fractionation according to the DAHANCA schedule 56 was used for patients with 
T2 or N1 oropharyngeal carcinomas, hypopharyngeal carcinomas and larynx carcinoma 
patients beyond stage T1N0. In patients with T1N0 glottic laryngeal carcinomas the fractio-
nation schedule was 60 Gy in 25 fractions over 5 weeksto the larynx only, using 2 lateral 
opposing fields.
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IMT MEASUREMENTS
IMT measurements were performed using the same protocol at baseline (before RT) and at 
follow-up. IMT was assessed at the common carotid artery (CCA) and the internal carotid 
artery (ICA) of both the left and right side. The location of measurement in the irradiated 
arteries was selected according to the high does RT field. The IMT was assessed in the highest 
quality ultrasonography approximate to the bifurcation. The dose of RT on the four IMT 
locations was extracted from the planning CT scan used for RT dose calculations.
 IMT was measured with one of the following linear array transducers: L17-5 connected to 
an iU22 Philips and UST-5539-7.5 MHZ connected to an ALOKA 5000. IMT pictures were 
digitally stored on the ultrasound machine or printed in case digital storage was not available. 
Printed images were then scanned at high resolution and interpolated (using Matlab 2010a) 
to obtain the same resolution as the digitally stored images. For all data, IMT was automatically 
measured by two investigators (JW, WR), using QLAB (Version 4.2.1, Philips). An edge-detection 
algorithm identified the lumen-intima and the media-adventitia interface within a region of 
interest (selected by the operator) over a maximally 10 mm long segment and calculated the 
mean IMT (Figure 1).
 Firstly, IMT at baseline, follow-up and delta IMT were calculated for irradiated (within the 
irradiated volume) and non-irradiated CCA and ICA apart. In case left and right carotid artery 
were both within the irradiated volume, mean IMT was calculated.
 Secondly, in the subgroup of unilateral irradiated patients IMT at baseline, follow-up and 
delta IMT of CCA and ICA were compared between the irradiated and the non-irradiated side 
within the same patient.
STATISTICAL ANALYSIS
Mean change in IMT between baseline and follow-up was compared using a paired T-test. 
Mean difference in change in IMT from baseline to follow-up between the irradiated and 
non-irradiated arteries was compared using a T-test. The comparisons were made firstly for 
all patients and secondly for the unilaterally irradiated patients only. ANOVA with change of 
IMT as outcome variable was used to analyze the relationship between patients or treatment 
characteristics and change in IMT. A p-value of < 0.05 was considered as statistically significant. 
The incidence rate of first-ever IS or TIA was calculated by dividing the total number of IS or 
TIA through the total sum of patient years at risk. The patient years at risk were calculated for 
each patient from baseline until date of last follow-up, death or IS/TIA.
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RESULTS
One-hundred-three patients were included in the current study between 2002 and 2008. 
(Figure 2). Patients had a follow-up visit between May 2011 and November 2013. At a median 
of 7 years, 51 patients had a follow-up visit. Another 14 patients underwent a follow-up only 
by telephone, because refusal or physical inability to travel to the hospital. From the 38 
patients out of follow-up, 24 died, mostly because of a secondary tumor (n=9) or progression 
of primary oncologic disease (n=7). 3 patients died because of a carotid bleeding, 1 because 
of a gastrointestinal bleeding, 1 hip fracture, 1 pneumonia and 2 had an unknown cause of 
death. From all patients out of follow-up, 2 had suffered from a stroke. Characteristics of our 
population at baseline are shown in table 1. In 48 patients ultrasonography to measure carotid 
IMT at late follow-up was completed.
 IMT in the irradiated CCA at baseline was 0.64 (SD 0.17) and at follow-up 0.74 (SD 0.24). 
(P=0.002). Mean increase of IMT in the irradiated CCA ’s (n=38) and non-irradiated CCA’s (n=14) 
was respectively 0.11 mm (SD 0.20) and 0.02 mm (SD 0.06) (p=0.03). IMT in the irradiated ICA 
at baseline was 0.55 (SD 0.12) and at follow-up 0.59 (SD 0.19). (P=0.395). Mean increase of 
IMT in the irradiated ICA ’s (n=19) and non-irradiated ICA’s (n=10) was respectively 0.03 mm 
(SD 0.16) and 0.02 mm (SD 0.10) (p=0.765). (Table 2)
 In the subgroup of patients that received unilateral RT (Table 3) delta IMT in the irradiated 
and non-irradiated CCA was 0.06 mm (SD 0.10) and 0.02 mm (SD 0.07), respectively (p>0.05).
 Baseline risk factors were, except for age, not associated with IMT increase or with IMT at 
follow-up. Per 10 years increase in age, IMT at follow-up was 0.05 mm thicker (p<0.05). 
Adjustment for baseline IMT did not influence these findings.
 From the 103 patients included, we had 546 person years of observation and 10 patients 
suffered from a first ever Transient Ischemic Attack or ischemic stroke. Incidence rate was 18 
per 1.000 person years. Incidence rate for ischemic stroke or Transient Ischemic Attack 
separately was 9 and 11 per 1.000 person years. Characteristics of these patients and their 
first ever stroke are shown in table 4. Mean age at stroke was 71 years and mean time interval 
from RT to stroke was 3 years. 90% of patients had one or more other cerebrovascular risk 
factors at baseline.
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DISCUSSION
Our long-term prospective study showed that RT of the neck is associated with an increase in 
carotid IMT at 7 years after RT. These results are in line with prior retrospective studies, 
showing a significant increase in IMT more than 10 years after RT 5. Other prospective studies 
are scarce and have a limited follow-up period between 3 months and 3 years. The strength 
of our study is the large group of participants with a long follow-up period. The IMT’s are 
measured with high precision using computer assisted analysis. The non-irradiated common 
carotid arteries showed a mean increase in IMT of 0.02 mm per 7 years, which is in accordance 
with the expected age related increase in patients described before 67. The IMT increase for 
the irradiated common carotid arteries was 0.11 mm, which was more than five times higher 
than the IMT increase in the non-irradiated arteries. Most likely, this difference can be 
attributed to the RT. In the smaller group of irradiated ICA’s we found the same trend, however 
this was not significant, probably because lack of power. Our study was done in a hetero-
geneous group of patients with different malignancies of the head and neck region. However 
the RT treatment protocols were homogeneous and because of this, our results have high 
external validity.
 A limitation of our study is the range in time of follow-up (between 4.5 and 9.6 years) after 
RT. The design of the study with an inclusion period between 2002 and 2008 forced us to this 
range in follow-up, because otherwise the analysis of the data would take much longer and, 
with time, more patients would be lost to follow-up. Another potential limitation is the lack 
of a control group. The ideal external control group would consist of patients with HNC and a 
similar cerebrovascular risk factor pattern, but without RT. However, such a group does not 
exist, because RT is the treatment of choice in patients with HNC and is therefore applied to 
most patients. Nevertheless, in the subgroup of patients treated with unilateral RT, internal 
control of irradiated versus non-irradiated carotid artery within the same patient was possible. 
Furthermore, there is a potential underestimation of the change in IMT, because we excluded 
patients with a prior stroke.
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 The increase in IMT we found is clinically relevant. A prior meta-analysis showed that the 
relative risk of stroke was 1.18 (95% CI 1.16-1.21) per 0.10 mm CCA IMT difference 63. The 
difference in delta IMT between the irradiated and the non-irradiated arteries exceeded this 
clinical significant range. When compared to the incidence rate of stroke in the age-matched 
Dutch population, our cohort had an increased risk with a factor 6. (8.9 versus 1.5 per 1.000 
person years). The incidence rate of stroke in our cohort with a median age of 54 years was 
comparable with the incidence rate of persons in their eighth decade. 68 Prevention of these 
long-term complications is a very important issue. Reducing the dose of RT is obviously the 
first solution to consider, however the cancer treatment requires a highly enough tumor dose. 
Modern high precision techniques such as Intensity Modulated Radiotherapy (IMRT) and 
Volumetric Modulated Arc Therapy (VMAT) definitely provide possibilities to spare the CCA 
and ICA. This obviously depends on the spatial relation between the tumor and the arteries. 
Furthermore, the majority of head and neck cancers require elective treatment of the draining 
lymph nodes situated along the internal jugular vein and carotid artery. In those situations it 
will be difficult to achieve doses <45-50 Gy to the CCA. Because stroke has a multifactorial 
etiology and RT is one of the risk factors, besides other cardiovascular risk factors, we think 
that another approach must be prevention of other contributable cardiovascular risk factors, 
like hypertension or smoking.
 In conclusion, patients treated for HNC with radiotherapy have increased risk for developing 
atherosclerosis of the carotid arteries and future stroke. Our results denote the need for 
further diagnostic and preventive strategies. HNC patients should be informed about these 
potential long-term complications and medical counseling to intervene with modifiable other 
cerebrovascular risk factors is mandatory.
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FIGURES AND TABLES
Figure 1 IMT measurements
Example of IMT measurement in a 72 year-old man treated for paroti d carcinoma 
with unilateral right sided radiotherapy 9 years before
A Left  distal caroti d artery
 dose RT: < 5 Gy
 IMT: 0.79 mm
B Right distal caroti d artery
 dose RT: 46 Gy
 IMT: 1.27mm
A B
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Figure 2 Flow chart
IMT = Inti ma Media Thickness US = Ultrasonography FU = Follow up
Baseline
(n=103)
IMT
Radiotherapy
Follow up
(n=65)
Site visit
(n=51)
IMT
(n=48)
Out of FU (n=38):
 Died 24
 Too ill 4
 Others 5
 Lost to FU 5
Telephone FU
(n=14)
No US
(n=3)
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Characteristi c n=65
Demographics
Men (%) 60
Age at baseline, years (mean, SD) 54.3 (13.3)
Follow-up post RT, years (mean, range) 6.7 (4.5–9.6)
Cancer diagnosis (%)
Carcinoma of larynx 45
Carcinoma of paroti d 14
Pleiomorphic adenoma of paroti d 15
Carcinoma of nasopharynx 2
Carcinoma  of oropharynx 17
Carcinoma  of hypopharynx 2
Lymphoma 6
Radiotherapy
Dose on irradiated caroti d arteries (Gy, mean, min-max, (SD))
CCA 58, 30–70, (12)
ICA 61, 30–70, (12)
Bilateral, % 63
CV risk factors at baseline (%)
Smoking 
Current smoker or stopped < 3 years ago 51
Former smoker or stopped > 3 years ago 23
Never smoked 25
Hypertension 26
Diabetes mellitus 5
Hypercholesterolemia 9 
Obesity 8 
Number CV risk factors at baseline* (%)
0 32
1 43
≥2 25
Table 1 Pati ent and treatment related characteristi cs at baseline
* Cerebrovascular (CV) risk factors at baseline consists of hypertension, diabetes, 
 hypercholesterolemia, overweight and current smoking.
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IMT baseline IMT FU Delta IMT Increase (%)
CCA RT+ (n=38) 0.64 (0.17)* 0.74 (0.24)* 0.11 (0.20)Δ 17
RT- (n=14) 0.55 (0.12) 0.57 (0.14) 0.02 (0.06)Δ 4
ICA RT+ (n=19) 0.55 (0.12) 0.59 (0.19) 0.03 (0.16) 5
RT- (n=10) 0.57 (0.25) 0.59 (0.18) 0.02 (0.10) 4
Table 2 IMT in the irradiated and non-irradiated arteries
IMT = Inti ma media thickness FU = Follow-up CCA = Common caroti d crtery ICA = Internal caroti d artery
Data are expressed as mean (SD).
* Paired T-Test for diff erence in mean CCA IMT at baseline and follow-up, p=0.002
Δ T-Test for diff erence in mean delta IMT in the irradiated versus not irradiated CCA, p=0.03
The unmarked diff erences were not signifi cant.
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IMT baseline IMT FU Delta IMT Increase (%)
CCA (n=11) RT+ 0.56 (0.12) 0.62 (0.12) 0.06 (0.10) 11
RT- 0.57 (0.13) 0.59 (0.15) 0.02 (0.07) 4
ICA (n=10) RT+ 0.52 (0.14) 0.58 (0.18) 0.06 (0.14) 12
RT- 0.57 (0.25) 0.59 (0.18) 0.02 (0.10) 4
Table 3 IMT in the subgroup of unilateral irradiated pati ents: intra-person comparison 
 between the irradiated and non irradiated arteries within the same pati ent
IMT = Inti ma media thickness FU = Follow-up CCA = Common caroti d crtery ICA = Internal caroti d artery
Data are expressed as mean (SD).
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Characteristi c n=10
Demographics
Men (%) 50
Age at baseline, years (mean, SD) 67 (10)
Cancer diagnosis (%)
Carcinoma of larynx 80
Carcinoma of paroti d 20
Characteristi cs ﬁ rst ever stroke
Type, IS/TIA (%) 50/50
Age at stroke, years, mean (SD) 71 (10) 
Interval RT/ stroke, years, mean ( SD) 3 (2.5)
TOAST (%)
LVD 50
SVD 10
Other / undetermined 40
Number CV risk factors at Baseline* (%)
0 10
1 70
≥2 20
Table 4 Characteristi cs of pati ents with fi rst ever stroke
IS = Ischemic stroke TIA = Transient ischemic att ack 
TOAST = Trial of Org 10172 in Acute Stroke Treatment classifi cati on 56 
LVD = Large vessel disease SVD = Small vessel disease RT = Radiotherapy 
IMT = Inti ma media thickness
* Cerebrovascular (CV) risk factors at baseline consists of hypertension, diabetes, 
 hypercholesterolemia, overweight and current smoking.
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ABSTRACT
BACKGROUND
In head and neck cancer (HNC) patients, long-term treatment related complications include 
radiotherapy (RT) induced carotid vasculopathy and stroke. The current study investigated the 
Magnetic Resonance Imaging (MRI) characteristics of the carotid wall in long-term HNC 
survivors treated with RT.
METHODS
MRI of the carotid arteries was performed within a prospective cohort of 42 HNC patients on 
average 7 years after RT. Two independent radiologists assessed maximal vessel wall thickness 
of common and internal carotid arteries. In case of wall thickening (≥2 mm) the MRI signal as 
well as length of the thickened segment were assessed.
RESULTS
Mean (SD) age of the 42 patients at baseline was 53 (13) years and mean (SD) follow-up time 
after RT was 6.8 (1.3) years. 62% were men and 60% had one or more cerebrovascular risk 
factors. Mean (SD) dose of RT on the common carotid arteries and internal carotid arteries 
was 57 Gy (11) and 61 Gy (10), respectively. Wall thickening was observed in 58% of irradiated 
versus 27% of non-irradiated common carotid arteries and 24% of irradiated versus 6% of 
non-irradiated internal carotid arteries (p< 0.05). Mean (SD) thickness of the irradiated and 
non-irradiated common carotid arteries was 2.5 (0.9) and 2 (0.7) mm (p=0.02). Mean thickness 
of the irradiated and non irradiated internal carotid arteries was 1.8 (0.8) and 1.5 mm (0.3) 
(n.s)Mean length of the thickened vessel wall was 48 mm versus 36 mm in the irradiated versus 
non-irradiated common carotid arteries (p= 0.03) and 20 mm versus 15 mm in the irradiated 
versus non-irradiated internal carotid arteries (n.s.). No significant differences were observed 
for signal intensities of the vessel walls.
CONCLUSIONS
Our study showed significantly more vessel wall thickening in irradiated versus non-irradiated 
carotid arteries years after RT for HNC, while no differences in signal intensities were observed.
KEYWORDS
Magnetic Resonance Imaging, head and neck cancer, carotid artery, radiation vasculopathy, 
adverse effects
511640-L-bw-Wilbers
Processed on: 25-7-2017 PDF page: 71
71
MRI OF THE CAROTID ARTERY IN LONG-TERM HEAD AND 
NECK CANCER SURVIVORS TREATED WITH RADIOTHERAPY
INTRODUCTION
Cancer and cardiovascular diseases are the two leading causes of morbidity and mortality 
world-wide1. Because of increased cancer survival rates long-term complications oftreatment 
become more prevalent. In head and neck cancer (HNC) patients, such complications include 
radiotherapy (RT) induced carotid artery vasculopathy and related ischemic strokes.
 In common carotid vasculopathy in the general population, the incidence of stroke is 
associated with the degree of stenosis and MRI characteristics of the atherosclerotic plaques, 
such as intra-plaque bleeding, lipid rich necrotic core and thinning of fibrous cap69,70 71. After 
unilateral RT of the neck, cross-sectional retrospective studies with duplex ultrasonography 
(DUS) showed an increased intima media thickness (IMT) of the irradiated compared to the 
non-irradiated carotid artery after a median follow-up period of 8-10 years 9,10. In a prospective 
follow-up study, we earlier described a significant increase in IMT measured on DUS from 
baseline to follow-up with a mean of 7 years after RT 72.
 Magnetic Resonance Imaging (MRI) studies investigating the incidence and characteristics 
of long-term complications of RT on carotid wall are lacking. The purpose of the present study 
therefore was to investigate the frequency, location and characteristics of RT induced 
vasculopathy in long-term survivors of HNC.
511640-L-bw-Wilbers
Processed on: 25-7-2017 PDF page: 72
72
LONG-TERM NEUROVASCULAR COMPLICATIONS IN CANCER PATIENTS
METHODS
STUDY POPULATION
This study was part of a prospective multicentre cohort study, designed to investigate the 
long-term vascular and cerebral complications after RT of the neck, using DUS, MRI and 
neuropsychologic testing.66
 In short, patients who had undergone RT of the neck because of HNC were prospectively 
recruited between 2002 and 2008 in two centers in the Netherlands specialized in head and 
neck oncology (the Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital (NCI/AvL), 
Amsterdam and the Radboud University Medical Center Nijmegen). Patients with a history of 
cerebrovascular disease were excluded. Patients were assessed for cerebrovascular risk factors 
at baseline. At follow-up on average 7 years after start of RT all patients underwent a MRI of 
the carotid arteries. The Medical Ethics Review Committee region of Arnhem-Nijmegen 
approved the study (NL 41008.091.12), and all patients gave written informed consent.
MRI PROTOCOL
MRI studies were performed on a 3 Tesla MR-scanner (Skyra, Siemens Erlangen) witha 3T TIM 
neck coil (Siemens AG, Head Neck 20, Munchen). MRI protocol of the carotids included a 3 
dimensional time of flight angiography (TOF), phase-contrast angiography (PCA), transversal 
T1,T2 and proton density (PD) sequences from the thoracic outlet to the skull base, and a 
sagittal oblique T2 of the carotid bifurcation. Finally, a maximum intensity projection (MIP) of 
the TOF and PCA sequences was reconstructed. Supplementary 1 shows a table with the 
parameters for the imaging sequences. The complete scanning protocol took approximately 
30 minutes.
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IMAGE REVIEW
All ratings were performed separately by two experienced neuro-radiologists. Image-quality 
was rated per sequence (3D TOF, T1, T2, PD) on a 4-point scale (1= not assessable, 4 = best) 
at 4 standard locations: right and left common carotid artery (CCA) and right and left internal 
carotid artery (ICA). The dose of RT on the 4 locations was extracted from the planning CT 
scan used for the RT dose calculations. Vessel walls with an image quality of 1 were excluded 
from analysis. Thickening of the vessel wall was defined according to previous studies, as a 
thickness of the vessel wall of at least 2 mm observed on the combination of sequences73,74. 
Characteristics of thickened vessel walls were scored as follows: greatest wall thickness (mm), 
length of thickening and distance from carotid bifurcation (mm) by visual inspection and 
extension along the circumference of the vessel wall on a 4 point scale (1=0-900, 2=90-1800, 
3=180-2700 and 4= 270-3600). Disruption of the fibrous cap and ulceration were scored on 3D 
TOF. Signal intensity (SI) of vessel wall thickening was scored on 3D TOF, T1, T2 and PD 
separately with the adjacent sternocleidomastoid muscle as reference (decreased, similar, 
increased). Stenosis were measured according to NASCET criteria 75. The thickness of the 
carotid wall measured by the two neuroradiologists separately was averaged to obtain one 
measure of vessel wall thickness and a separation of thickened versus non-thickened vessel 
walls. For all other scores, consensus was reached by both observers in case of 
inconsistencies.
STATISTICAL ANALYSIS
Categorical variables were analyzed by the Fisher exact test. Differences in continuous variables 
were analyzed by independent t-test and expressed as mean differences (SD).
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RESULTS
103 patients were included in the study during initial inclusion between 2002 and 2008. After 
a mean follow-up time of 7 years (SD 1.3) after start of RT 42 patients underwent MRI ( supple-
mentary 2). Baseline characteristics are reported in table 1. At a median of 7 years, 51 patients 
had a follow-up visit. Another 14 patients underwent a follow-up by telephone only, because 
refusal or physical inability to travel to the hospital. From the 38 patients out of follow-up, 24 
died, mostly because of a secondary tumor (n=9) or progression of primary oncologic disease 
(n=7). Three patients died because of a carotid bleeding, 1 because of a gastrointestinal 
bleeding, 1 because of complications after hip fracture, 1 because of pneumonia and 2 had 
an unknown cause of death. From all patients out of follow-up, 2 had suffered from a stroke.
MRI examinations of the carotid arteries resulted in 84 measurements of CCAs and 83 
measurements of ICAs. One ICA was occluded due to dissection and hence measurement was 
not possible. No vessels had to be excluded because of insufficient image quality.
CAROTID WALL THICKENING
From the total of 84 assessed CCAs, 62 (74%) were located within and 22 (26%) outside the 
RT portal. From the irradiated CCAs 58% had a thickening of the vessel wall versus 27% of the 
non-irradiated CCAs (p< 0.05, Table 2). 34 (41%) of the ICAs were located within the RT portal 
and 49 (59%) outside the RT portal. From the irradiated ICAs 24% had a thickening of the vessel 
wall versus 6% of the non-irradiated ICAs (p< 0.05). From the irradiated CCAs, 45% had a vessel 
wall thickness ≥ 2.5mm versus 18% of the non-irradiated CCAs (p<0.05). From the irradiated 
ICAs, 12% had a vessel wall thickness ≥ 2.5mm versus 0% of the non-irradiated ICAs. (p<0.05). 
Mean (SD) thickness of the irradiated and non-irradiated CCAs was 2.5 (0.9) and 2 (0.7) mm 
(p=0.02). Mean thickness of the irradiated and non irradiated ICAs was 1.8 (0.8) and 1.5 mm 
(0.3) (n.s)In the subgroup of patients with unilateral RT mean thickness in irradiated vs non-ir-
radiated CCAs (n=14) and ICAs (n=17) was 2.24 vs 2.20 mm (n.s) and 1.72 vs 1.45 mm (n.s)
 The length of the thickened CCA wall was 48 mm in the irradiated and 36 mm in the non-ir-
radiated arteries (p<0.05). In the thickened ICAs this was 20 and 15 mm respectively (n.s). 
20% of the irradiated and thickened CCA vessel walls had a circumferential thickening of >1800 
versus 0% in the non-irradiated CCAs. In the thickened ICAs this was 26% and 0% respectively. 
Ruption of the cap or signs of ulceration were not seen. In 91% of the irradiated and 67% of 
the non-irradiated CCAs grade of stenosis was 0-50%. There were no CCAs with a stenosis of 
> 50%. In the ICAs 86% of the irradiated and 50% of the non-irradiated arteries had 0-50% 
stenosis. One irradiated ICA had a stenosis of > 50% (Table 3). Pattern of intensities on each 
of four sequences was not different between the irradiated and the non-irradiated arteries.
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DISCUSSION
This is the first MRI study to investigate the frequency, location and characteristics of RT 
induced vasculopathy in long-term survivors of HNC. Significantly more vessel wall thickening 
was observed in irradiated versus non-irradiated carotid arteries years after RT for HNC, while 
no differences in signal intensities were observed.
 Previous cross-sectional retrospective studies using DUS showed a larger IMT in the 
irradiated as compared to the non-irradiated carotid arteries after a median follow-up period 
of 8-10 years after unilateral RT of the neck 5,9,10, with an associated increased risk of ischemic 
stroke 6. This finding was confirmed prospectively in a follow-up side study of our current 
cohort study 72 DUS however has several disadvantages which may be overcome with MRI. 
First, using DUS it is not possible to evaluate the course of the whole CCA and ICA. Second, 
using conventional DUS techniques it is more difficult to evaluate the precise characteristics 
of the vessel wall changes 71.
 Using MRI, we observed significantly more vessel wall thickening in irradiated versus non-ir-
radiated carotid arteries, over a significant longer course, and with a trend towards more 
circumferential thickening. These findings are in line with a recent study assessing the 
angiograpic features of 96 patients with a first ever ischemic cerebral event attributed to 
symptomatic occlusive radiation vasculopathy76. When compared to an age-matched cohort 
without prior RT, CCA and ICA were diffusely involved and the stenosis were more frequently 
tandem and bilateral.
 No significant differences in MRI signal intensities were observed between the thickened 
vessel walls in irradiated and non-irradiated arteries. An explanation of this finding could be 
that RT induced atherosclerosis is an accelerated age related atherosclerosis with similar vessel 
wall composition and hence similar MRI signal intensity changes. Another explanation could 
be under powering of the current study for this observation. Moreover, at the time of the 
study a dedicated high resolution coil for the carotids was not available, and images were 
acquired using a standard neck coil. At last, the relatively small degree of stenosis in this study 
may indicate an early stage of long-term vascular changes after RT, which may become more 
evident over time .
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 Although this study involved only 42 patients at follow-up, this is the largest prospective 
cohort of HNC survivors with the longest follow-up period described up to now. However, a 
methodological limitation of the current study was the lack of a baseline MRI, which prevents 
us from studying changes over time and hence from making causal inferences about the effect 
of RT.Another limitation, is the lack of an external control group.The ideal external control 
group would consist of HNC patients not treated with RT matched for cardiovascular risk 
factors. Since RT is the treatment of choice in locally advanced HNC, this control group does 
not exist. In the subgroup of unilateral irradiated patients, the non-irradiated carotid artery 
could serve as an internal control within a single patient. Although this subgroup was too small 
to reach significant level, we found a trend towards more pathologic vessel wall changes in 
the irradiated arteries. Unfortunately, it was not possible to study the influence of RT dose 
and/or other cardiovascular risk factors on vessel wall changes, because subgroups were too 
small and power insufficiently.
 No guidelines exist to prevent long-term vascular and cerebral changes after RT in HNC. 
However, the current study appeals for the need of preventive strategies. Patients need to be 
informed about the potential vascular long-term complications and other concomitant 
cerebrovascular risk factors associated with increased risk of stroke, like smoking, physical 
inactivity, atrial fibrillation, hypertension and diabetes should be checked regularly and treated 
were possible.Future studies focusing on preventive strategies should comprise a larger patient 
cohort, with longer follow-up duration after RT.
 In conclusion, our MRI study showed significantly more vessel wall thickening over a longer 
trajectory in irradiated carotid arteries 7 years after radiotherapy as compared to the non-ir-
radiated carotid arteries in the same patient group. Survivors of HNC treated with neck RT 
have to be informed about the increased risk of carotid artery pathology andpotential 
long-term complications and should be instructed about other modifiable cerebrovascular 
risk factors. Future studies should focus on potential preventive strategies.
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FIGURES AND TABLES
Figure 1 MRI
Example of MRI in a 72 year-old man treated for paroti d carcinoma 
with unilateral right sided radiotherapy nine years before.
Left  CCA, dose RT: < 5 Gy
Thickness: 1.50 mm
Right CCA, dose RT: 46 Gy
Thickness: 4 mm
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Characteristi c n=42
Demographics
Men (%) 62
Age at baseline, years (mean, SD) 53 (13)
Follow-up post RT, years (mean, SD) 6.8 (1.3)
Cancer diagnosis (%)
Carcinoma of the larynx 36 
Carcinoma  of the paroti d 14
Adenoma of the paroti d 19
Carcinoma of the nasopharynx 2
Carcinoma of the oropharynx 21 
Carcinoma of the hypopharynx 2
Lymphoma 5
Radiotherapy
Dose on irradiated caroti d arteries (Gy, mean, min-max, (SD))
CCA 57, 30–70 (11)
ICA 61, 30–70 (10)
Bilateral (%) 57
Length of caroti d in RT portal, cm (mean, min-max, (SD)) 9, 4–16 (3)
CV risk factors at baseline (%)
Smoking 
Current smoker or stopped < 3 years ago 43 
Former smoker or stopped > 3 years ago 29 
Never smoked 29 
Hypertension 21 
Diabetes mellitus 2
Hypercholesterolemia 10
Obesity 5
Number CV risk factors at Baseline‡ (%)
0 risk factors 41
1 risk factors 41
≥ 2 risk factors 19
Table 1 Pati ent and treatment related characteristi cs
CCA = Common Caroti d Artery
ICA =  Internal Caroti d Artery
* Cerebrovascular (CV) risk factors at baseline consists of hypertension, 
 diabetes, hypercholesterolemia, overweight and current smoking.
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CCA (n=84) ICA (n=83)
RT+ (n=62) RT– (n=22) RT+ (n=34) RT– (n=49)
Mean thickness, mm (SD) 2.5 (0.9) 2.0 (0.7)* 1.8 (0.8) 1.5 (0.3)*
Thickness ≥ 2mm, n (%) 36 (58) 6 (27)† 8 (24) 3 (6)†
Thickness ≥ 2.5mm, n (%) 28 (45) 4 (18)† 4 (12) 0 (0)†
Table 2 Vessel wall thickening on MRI
CCA = Common caroti d crtery ICA = Internal caroti d artery RT = Radiotherapy
* Independent T-test for diff erence between irradiated and non-irradiated CCA, p = 0.02 and ICA, p = 0.09
† Fischer exact test for diff erence between % irradiated and non-irradiated CCA and ICA, p < 0.05
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Table 3 Characteristi cs of caroti d walls if thickness ≥ 2 mm
CCA (n=42) ICA (n=11)
RT+ (n=36) RT– (n=6) RT+ (n=8) RT– (n=3)
Measurements, mean mm (SD)
Length of thickened part 48 (12) 36 (13)* 20 (12) 15 (8)
Distance from bulbus 7.6 (8.3) 8.8 (9.3) 1.9 (3.4) 2.6 (2.4)
Degree of circumferenti al 
thickening, number (%)
90–180 degree 29 (81) 6 (100) 6 (75) 3 (100)
180–270 degree 6 (17) 1 (13) 0 (0)
270–360 degree 1 (3) 1 (13) 0 (0)
Intact cap, number (%) 36 (100) 6 (100) 8 (100) 3 (100)
Ulcerati on, number (%) 0 (0) 0 (0) 0 (0) 0 (0)
Stenosis grade, number (%)
0 3 (8) 2 (33) 0 (0) 1 (33)
0–50 33 (92) 4 (67) 7 (88) 2 (67)
50–99 0 (0) 0 (0) 1 (13) 0 (0)
CCA = Common caroti d artery ICA = Internal caroti d artery RT = Radiotherapy
Data are expressed as number (%).
Unmarked variables are not stati sti cally signifi cant between the irradiated and the non-irradiated arteries.
* Independent T-test for diff erence between irradiated and non-irradiated CCA, p 0.03
Unmarked results are not signifi cant diff erent between the irradiated and non-irradiated arteries.
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SUPPLEMENTARY
Sequences TR 
(msec)
TE 
(msec)
Slice 
(mm)
Flip angle
 (degree)
Voxel size
 (mm)
3D TOF 20 3.11 1 25 0.5x0.5x1.0
3D PCA 40 5.95 0.9 15 0.4x0.4x0.9
Tr. T1 TSE 600 12 3 160 0.3x0.3x3.0
Tr. T2 TSE 4540 85 3 164 0.3x0.3x3.0
Sag. T2 TSE 3460 115 3 160 0.5x0.5x3.0
PD TSE 4010 11 3 172 0.3x0.3x3.0
Supplement 1 MRI parameters
TR = Repeti ti on Time TE = Echo Time 3D TOF = Threedimensional ti me of fl ight angiography 
3D PCA = Threedimensional phase-contrast angiography Tr. T1 TSE = Transversal T1 Turbo Spin Echo 
Tr. T2 TSE = Transversal T2 Turbo Spin Echo Sag. T2 TSE = Sagital T2 turbo spin echo 
PD TSE = Proton density Turbo Spin Echo
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Supplement 2 Flow chart
Baseline
(n=103)
Radiotherapy
Follow up
(n=65)
Site visit
(n=51)
MRI caroti d arteries
(n=42)
Out of FU (n=38):
 Died 24
 Too ill 4
 Emigrated 1
 Too far travelling 2
 Others 3
 Unknown reason 4
Telephone follow up
(n=14)
No MRI:
 Contra indicati on MRI 7
 Technical reason 2
FU = Follow up
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ABSTRACT
BACKGROUND
Long-term cancer treatment complications become more prevalent as survival improves. Little 
is known about the psychological complications in long-term survivors of head and neck cancer 
(HNC). We investigated cognitive functioning and its relation with depression, fatigue, cognitive 
complains as well as brain lesions on MRI.
METHODS
This study is part of a multicentre prospective cohort study in 65 patients treated for HNC. A 
comprehensive neuropsychological assessment was combined with validated questionnaires 
on subjective memory complaints, depression and fatigue after a median of 7 years follow-up. 
Results were compared with age and education adjusted normative data. Further, we evaluated 
cerebral white matter hyperintensities (WMH), brain volume and infarctions on MRI.
RESULTS
HNC patients had a worse cognitive performance in two of the five assessed cognitive domains: 
episodic memory (z=-0.48, p=0.003) and speed of information processing (z=-0.47, p < 0.001). 
Patients with fatigue performed worse than patients without fatigue on verbal fluency (mean 
difference in z-score 0.52, p=0.02) and speed of information processing (0.49, p=0.04). Patients 
with subjective memory complains had a worse episodic memory performance (mean 
difference in z-score -0.96; p=0.02). Patients with cerebral infarction(s) on MRI performed 
worse on fluency (mean difference in z-score 0.74, p=0.005). A lower cognitive performance 
was not associated with depression, WMH or brain volume.
CONCLUSION
Long-term HNC survivors showed worse cognitive functioning 7 years after treatment. 
Cognitive function was associated with subjective complaints and fatigue, but not with 
depressive symptoms. Cerebral infarctions on MRI were correlated with cognitive function, 
whereas WMH and brain volume were not.
KEYWORDS
Head and neck cancer, cognition, depression, fatigue, white matter hyperintensities
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INTRODUCTION
Increased successful treatment for cancer have resulted in a growing population of long-term 
survivors. A consequence is a parallel increase in long-term treatment-related complications. 
A well known long-term complication of radiotherapy (RT) of the neck is carotid artery 
vasculopathy, which ultimately can lead to stroke 5,6. In the current study cohort, we previously 
showed a significant increase in carotid wall pathology and stroke risk in the first seven years 
after RT 72. Apart from this known direct radiation-related damage, limited clinical data exist 
on long-term cognitive function, mood, fatigue and quality of life (QoL).
 In the general population vascular white matter hyperintensities (WMH) and silent brain 
infarctions are related to cognitive impairment, depression and risk of dementia 19-21. Small 
prospective studies showed evidence of cognitive failure in HNC patients within the first two 
years after RT 77,78. A high rate of depression with preserved QoL was observed in 5 year 
survivors of HNC 79. To date, no long-term prospective studies assessing the relation between 
cognitive functioning, depression and fatigue exist in these patients. The aim of the current 
study was to evaluate cognitive functioning, depression, fatigue, QoL and their interrelation 
seven years after treatment with RT in HNC patients. Furthermore, we assessed WMH, atrophy 
and infarctions on brain MRI. We hypothized a multifactorial etiology of cognitive problems 
in long term HNC survivors, consisting of RT induced carotid vasculopathy, patients characte-
ristics like fatigue or depression and vascular changes of the brain, like cerebral infarctions.
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METHODS
This study was a part of a multicentre prospective cohort study, designed to investigate the 
long-term vascular and cerebral complications after RT of the neck. Details of this study and 
the treatment protocols have been described elsewhere 66.
 In short, patients were prospectively recruited 7 years ago in two centers of the Netherlands 
(the Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital (NCI/AvL), Amsterdam 
and the Radboud University Medical Center, Nijmegen). Inclusion criterion was RT of the neck 
because of a HNC, that included carcinoma of the larynx, parotid, nasopharynx, oropharynx, 
hypopharynx, pleiomorphic adenoma of the parotid and lymphoma (table 1). Patients were 
assessed for cerebrovascular risk factors at baseline; patients with an history of cerebro-
vascular disease were excluded. At follow-up 7 years after RT all patients underwent a 
standardized NeuroPsychological Assessment (NPA) and fulfilled self-reported questionnaires 
about cognitive complaints, depression, fatigue and quality of life (QoL). The Medical Ethics 
Review Committee approved the study (NL 41008.091.12). All patients gave written informed 
consent.
RADIATION THERAPY
Radiotherapy was usually given with a linear accelerator using 4-6 MV photons with the patient 
immobilized using a thermoplastic mask. The target area included at least the unilateral neck 
consistent to the tumor side, including part of the carotid artery system (e.g. in case of parotid 
tumors or well lateralized oropharyngeal carcinomas). In other patients, both sides of the neck 
and the vascular system were irradiated (e.g. in case of laryngeal or hypopharyngeal 
carcinoma).
 The radiation treatment was delivered with external beam radiotherapy using either 
standard techniques (parallel opposing beams or wedge-pair techniques) or Intenisity-
Modulated Radiotherapy (IMRT), depending on resources.
 The radiation dose given was typically 30-36 Gy for lymphoma, 50-60 Gy for parotid tumors 
(pleiomorphic adenoma or parotid carcinoma), 60-70 Gy for laryngeal carcinoma and 70 Gy 
for oropharyngeal and hypopharyngeal carcinoma. In the majority of cases, 2 Gy per fraction 
was delivered up to the specified total dose. For patients with lymphoma, parotid tumors or 
T1N0 oropharyngeal carcinoma, a standard once-daily fractionation schedule was used. 
Accelerated fractionation was used for patients with T2 or N1 oropharyngeal carcinomas, 
hypopharyngeal carcinomas and larynx carcinoma patients beyond stage T1N0. In patients 
with T1N0 glottic laryngeal carcinomas the fractionation schedule was 60 Gy in 25 fractions 
over 5 weeks to the larynx only, using 2 lateral opposing fields. In few cases with large nodal 
metastases in the upper neck the base of the posterior cranial fossa received some radiation 
dose, but always less than 30 Gy. In the Netherlands standard treatment protocols of early 
stage HNC patients do not include chemotherapy or targeted therapy.
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NEUROPSYCHOLOGICAL ASSESSMENT
NPA was administered between November 2012 and October 2013 by a trained neuropsy-
chologist. Education level was classified using 7 categories based on the Dutch educational 
system; one being less than primary school and seven reflecting an academic degree 80 . The 
Mini Mental State Examination (MMSE) 26 and the Frontal Assessment Battery (FAB) 27 were 
used asdescriptive tools of overall cognitive function and orientation. An extensive objective 
test battery covered 5 cognitive domains; 1. Episodic memory was assessed using the five-trial 
Dutch version of the Rey Auditory Verbal Learning Test (RAVLT) in which the ability to acquire 
and retain new verbal information was measured, immediately and after a delay 28; total 
number of correctly recalled words over trials 1 to 5 was used as measure for immediate 
memory; total number of words recalled after a delay was used as delayed recall measure. 
2. Working memory was assessed by using the Digit Span test 30, both forwards and backwards. 
3. Executive functioning was assessed using the Dutch version of the Stroop Color-Word Task; 
this tasks consists of three cards, that is, Card I – the word card - which contains color words 
in black ink that have to be read, Card II – the color card - that consists of colored patches the 
color of which has to be named, and Card III – the color-word card – which contains color 
names printed in an incongruent color that have to be named (i.e., the word “yellow” printed 
in red). TheStroop interference score was used here as a measure of response inhibition (i.e., 
number of seconds needed to complete Card III/ mean number of seconds needed to complete 
Cards I and II)) 31; and the Brixton Spatial Anticipation Test (Brixton) that measures rule 
detection and set shifting 34,33. 4. Verbal fluency was assessed using two tasks. First, a semantic 
fluency task 35 in which participants had to name as many animals as possible within 60 
seconds followed by as many professions within 60 seconds. Second, a letter fluency task 36 
in which as many words beginning with a given initial letter (D-A-T) had to be generated within 
60 seconds. 5. Speed of information processing was evaluated by using three tasks; the Stroop 
test (mean score Parts I and II) and the Symbol Digit Substitution Task 37, which is a modified 
version of the Symbol Digital Modalities Task.
 For each individual, performance on the neuropsychological tests was adjusted for age and 
education level using available neuropsychological normative data sets and converted into 
standardized z-scores. The compound domain scores were constructed by averaging the 
z-scores of the used subtests. For classification of a test performance to be clinically impaired, 
the age- and education-adjusted individual z-score had to be lower than -1.65, corresponding 
with the 5th percentile 81.
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SUBJECTIVE MEMORY COMPLAINTS, DEPRESSION, FATIGUE AND QoL
Subjective Memory Complaints were assessed by a 15-item semi-structured interview based 
on the Cognitive Failure Questionnaire 82,20. The Center for Epidemiologic Studies Depression 
Scale (CES-D) 83 was used to diagnose a probable depression (score ≥16). Fatigue was assessed 
by using the Checklist on Individual Strength (CIS-20R) 39. A score > 27 indicated a heightened 
experience of fatigue 39. QoL was assessed with the Short Form 36 Health Survey (SF-36) 40. 
For each individual, performance on the SF-36 subdomains was adjusted for age using available 
Dutch normative data.
MRI
The MRI studies were performed on a 3 Tesla MR-scanner (Skyra, Siemens Erlangen). The 
scanning protocol included T1 TSE, T2 TSE and T2 Fluid Attenuated Inversion Recovery (FLAIR) 
transversal sequences of the brain. Parameters for the imaging sequences were as follows: 
1. T1 (Repetition Time (TR)/Time to Echo (TE) 500/9.2 ms, slice thickness 5 mm, flip angle 70 
degree, voxel size 0.7x0.7x5 mm), 2. T2 TR/TE 3500/92 ms, slice thickness 5 mm, flip angle 
120 degree, voxel size 0.4x0.4x5 mm and 3. T2 FLAIR TR/TE 9000/ 87 ms, slice thickness 5 mm, 
flip angle 150 degree, voxel size 0.6x0.6x5mm. The complete scanning protocol took approxi-
mately 10 minutes. Total white matter hyperintensities (WMH) were manually segmented on 
FLAIR images and the volume of WMH was calculated by summing the segmented areas 
multiplied by slice thickness. Total white matter (WM), gray matter (GM) and Cerebrospinal 
Fluid Volume (CSF) volume were calculated by brain volumetry using a six class segmentation 
tool Statistical Parametric Mapping Software (http://www.fil.ion.ucl.ac.uk/spm) (SPM 8) on 
the T1 images. The volumes were calculated by summing all the voxel volumes belonging to 
the tissue class. We used the formula: (WM volume + GM volume) / (WM + GM + CSF volume) 
as a covariate to adjust for total brain volume 84. Brain infarctions were rated separately by 
two experienced neuro-radiologists. In case of inconsistency, a consensus meeting was held. 
The MRI protocol included a 3 dimensional time of flight angiography (TOF) of the carotid 
arteries to measure grade of stenosis.
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STATISTICAL ANALYSIS
Mean composed z-scores were calculated for each cognitive domain by averaging the z-scores 
of the individual tasks in that domain. These mean z-scores of the HNC group were statistically 
compared to the normative standardized mean (z=0) using one-sample t-tests. Also, the 
frequency of patients classified as ‘cognitively impaired’ at an individual level was quantified 
for each neuropsychological test. The results of the SF-36 were also analyzed by calculating a 
mean z-score, testing against z=0 by using a one sample T-test and defining an abnormal score 
as z-score ≤-1.65. The relation between subjective memory complaints, depression or fatigue 
and cognitive functioning was tested by comparing mean composed z-scores per cognitive 
domain with an independent T-test. ANCOVA was used to test the relation between volume 
of WMH (with correction for brain volume) or brain volume (with correction for age) and 
composed z-scores on the cognitive domains. Total volume of WMH was log transformed. The 
relation between the presence of brain infarctions on MRI and cognitive functioning was 
determined by comparing mean composed z-scores per cognitive domain with an independent 
T-test. Effect sizes were calculated for all comparisons (Cohen’s d).
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RESULTS
A total of 103 patients fulfilled the inclusion and exclusion criteria for our study. The number 
of patients lost to follow-up is reported in figure 1; no significant differences were found 
between patients with exclusion criteria for NPA or MRI and those without exclusion criteria 
for NPA or MRI on baseline age (means (SD)) 52 (14) and 55 (13) respectively; Mann Whitney 
U test, p=0.5, sex distribution (9:4: and 30:22 ratio male:female respectively, Pearson 
Chi-Square, p=0.4) and education levelmeans (SD) 4.6 (1.9) and 4.9 (1.3) respectively, Mann 
Whitney U test, p=0.9. A total of 65 patients completed the questionnaires. Fifty-one patients 
had a follow-up protocol between November 2012 and November 2013. In total, an NPA was 
administered in 44 patients, 38 of whom also underwent a MRI of the brain. Characteristics 
of our sample at baseline are reported in table 1. Mean follow-up time after RT was 6.7 (range 
4.5-9.6) years, mean age at FU was 54 years.
OBJECTIVE COGNITIVE FUNCTIONING
One patient obtained an MMSE-score below 24. No patients obtained a below cut-off score 
on the FAB. The composed mean age- and education adjusted z-scores were significantlyworse 
at group level on two cognitive domains: episodic memory z=-0.48 (p= 0.003) and speed of 
information processing z= – 0.47 (p<0.001). No group differences were found on working 
memory, executive functioning and verbal fluency. Examining the percentages of patients 
classified as being ‘cognitively impaired’ (compared to the expected 5% impaired individuals 
in the normative sample using a cut-off of z=1.65), 11.4% of the patients were classified as 
being clinically impaired on the domain episodic memory and 6.8% were impaired on the 
domain speed of information processing (note that in the domain working memory, the 
percentage impaired patients (4.5%) is within the expected rate of impairment). (Table 2)
SUBJECTIVE COGNITIVE COMPLAINTS, DEPRESSION, FATIGUE AND QoL
The proportion of patients having subjective memory complaints, depressive symptoms (CES-D) 
or abnormal fatigue, were 80%, 21%, and 36%, respectively (Table 4). Domain specific QoL 
scores were not significantly different from norm scores of the general population, except for 
a trend towards a lower z-score on the subdomain General health (z=-0.26, p=0.05) (Table 3). 
Patients with subjective memory complaints performed significantly worse than patients 
without subjective memory complaints on episodic memory (mean difference in z score 0.96, 
p=0.02, d= -1.0). Patients with fatigue scored significantly worse than patients without fatigue 
on verbal fluency (mean difference in z-score 0.52, p=0.02, d= -0.7) and speed of information 
processing (mean difference in z-score 0.49, p=0.04, d= -0.7). Mean z-score per cognitive domain 
for patients with or without depressive symptoms was not significantly different (Table 4).
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WHITE MATTER HYPERINTENSITIES, BRAIN VOLUME, INFARCTIONS ON MRI  
AND CAROTID STENOSIS
The 38 MRIs showed 14 infarctions in 9 patients (5 patients had 2 infarctions). Only one patient 
had a microbleed. From the 14 infarctions, 7 were (sub)cortical, 4 watershed and 3 lacunar. 
Seven infractions were located in the anterior circulation (all in irradiated vascular territory) 
and seven were located in the posterior circulation.
 Mean (SD) volume of gray matter, white matter and cerebral spinal fluid was 610.0 (57.8), 
512.2 (52.8) and 268.3 (32.3) ml, respectively. Mean (SD) volume of WMH on MRI was 18.9 
ml. No correlations were found between volume of WMH (with correction for brain volume) 
or brain volume (with correction for age) and the cognitive domain z-scores. Patients with one 
or more brain infarctions on MRI performed worse than patients without brain infarctions on 
verbal fluency (mean difference in z-score 0.74, p= 0.005, d= -1.1) Cerebral infarctions were 
not correlated with the other cognitive domains. Only one patient had a carotid artery stenosis 
of more than 50%, which was in the high dose RT portal. Unfortunately, no subgroup analysis 
was possible on carotid pathology.
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DISCUSSION
The current study showed worse functioning in some cognitive domains in long-term HNC 
survivors on average seven years after treatment compared to the general population. A lower 
cognitive performance in this cohort was associated with subjective memory complaints and 
fatigue, but not with depression. Brain infarctions on MRI were correlated with worse cognitive 
function (verbal fluency); whereas WMH and brain volume were not. Carotid artery 
vasculopathy on MRI was mild. QoL was relatively spared.
 Although attention for long-term physical complications in HNC survivors is growing, limited 
clinical data exist on the long-term neuropsychological sequelae. The current study is the first 
long-term follow-up study combining cognitive functioning, depression, fatigue, QoL and brain 
imaging. The cognitive test battery consisted of sensitive and widely-used neuropsychological 
tests for which good normative data are available. We showed that on average seven years 
after treatment HNC patients had a worse cognitive functioning on episodic memory and 
speed of information processing. Previous prospective studies in small samples (n =10-30) 
and relatively short follow-up durations (12-20 months) also showed impaired cognitive 
functioning after RT of the neck, especially in the memory domain 77,78. Larger studies with 
longer follow-up time are to date lacking. Since cognitive function can be influenced by several 
conditions, it is important to find the underlying mechanisms. In our cohort of long-term 
survivors, a worse cognitive functionwas related to subjective memory complaints and fatigue, 
but not to depression. This is a clinically useful finding, because it demonstrates the importance 
of screening for subjective memory complaints and fatigue in long-term survivors after RT of 
the neck. Furthermore, brain infarctions on MRI were associated with impaired cognitive 
function. Therefore, counseling of patients on the importance of preventing cardiovascular 
risk factors is a potential prevention strategy that could be studied in future. However, a trial 
on screening and prevention of cardiovascular risk factors, infarctions and cognition is probably 
not feasible, because follow-up duration has to be several years. Cancer-related fatigue affects 
70-100% of the cancer patients population 85 even months to years after treatment 86, which 
results in substantial adverse physical, psychosocial and economic consequences for both 
patients and caregivers87. Studies assessing cancer-related fatigue specific for HNC patients 
are scarce. Short-time follow-up studies reporting increased levels of fatigue during the 
treatment period reaching a peak on the sixth week of RT88. To date, long-term studies on 
fatigue in HNC patients are lacking. Because cancer-related fatigue has physical, psychosocial 
and economic consequences, the identification and treatment of this symptom is important, 
even in long-term HNC survivors, since evidence-based clinical practice guidelines are available 
85. Because only one patient had a > 50% carotid artery stenosis, we could not assess a relation 
between RT induced carotid vasculopathy and cognitive decline. Our results showed relatively 
sparing of QoL. These results are in line with previous HNC studies with follow-up durations 
until 2 years after RT thatreported detioriation in QoL, which improved over time 89. In a 
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recently published cross-sectional analyses of 50 HNC survivors (at least 5 years after RT ) 80% 
of the patients indicated to be satisfied with their QoL 79.
 There were some limitations of the current study. Firstly, no baseline (i.e. pre-RT) 
assessments of cognition, subjective memory complaints, depression, fatigue or QoL were 
available, which prevents us from studying changes over time and hence from making causal 
inferences about the effect of RT. To study the RT effect on cognitive performance, the optimal 
study design would be a randomized controlled trial with a control group consisting of HNC 
patients who had not been treated with RT. However, since RT is the treatment of choice in 
early stage HNC, such a design is neither realistic nor ethical approvable. We used age- and 
education-adjusted externally validated normative data for the cognitive assessments and the 
QoL questionnaire, to compare the cognitive performance of HNC survivors with the general 
population. Secondly, because the current cohort is not a random sample of HNC survivors, 
there is a potential selection bias of relatively healthy study subjects that could have resulted 
in an underestimation of the cognitive decline and vascular changes. A substantial part of our 
study population had a contra-indication for either the NPA or the MRI. However, we do not 
think that the exclusion criteria for MRI or NPA, like claustrophobia or not having Dutch as the 
primary language, have influenced the relationship under study, as baseline characteristics 
did not differ between the two groups. Thirdly, because we had no data about the cardio-
vascular risk factors of the general population, we could not adjust for life style factors. Finally 
information bias is possible, because the psychological assessments in our cohort was not 
performed blindly. However, we do not expect a directl influence on the evaluation of the 
assessments.
 In conclusion, this is the first study assessing the psychological complications in long-term 
HNC survivors. We showed a worse cognitive functioning and more cognitively impaired 
patients in the domains episodic memory and speed of information processing. A lower 
cognitive performance was associated with subjective memory complaints and fatigue, but 
not with depression. Furthermore, cerebral infarctions on MRI were also related to worse 
cognitive functioning; WMH and brain atrophy were not. There is a need for more awareness 
of cognitive dysfunction, fatigue and cerebral infarctions in long-term HNC survivors. Screening 
and prevention guidelines regarding these psychological complications have to be implemented 
in the standard of care for long-term HNC survivors.
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FIGURES AND TABLES
Figure 1 Flow chart
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Table 1 Pati ent and treatment related characteristi cs at baseline
Characteristi cs n=65
Demographics
Men (%) 60
Age at baseline, years (mean, SD) 54.3 (13.3)
Follow-up post RT, years (mean, SD) 6.7 (1.2)
Radiotherapy Dose on irradiated caroti d arteries (Gy, mean, min-max, (SD))
CCA 58, 30–70, (12)
ICA 61, 30–70, (12)
Bilateral (%)  63
Cancer diagnosis (%)
Carcinoma of paroti d 14
Pleiomorphic adenoma of paroti d 15
Carcinoma of nasopharynx 2
Carcinoma of oropharynx 17
Carcinoma of hypopharynx 2
Lymphoma 6
Number CV risk factors at baseline* (%)
0 32
1 43
≥2 25
Educati on level‡ at follow-up (mean, SD) 5 (1.4)
Marital status at follow-up married (%) 66
 widowed (%) 9
 divorced (%) 8
 never married (%) 17
Employment status at follow-up working (%) 42
 full or parti ally unemployed (%) 6
 reti red (%) 44
 other (%) 8
RT = Radiotherapy CCA = Common caroti s artery ICA = Internal caroti d artery
* Cerebrovascular (CV) risk factors at baseline consists of: hypertension, diabetes, 
 hypercholesterolemia, overweight and current smoking.
‡ Educati on level is classifi ed using seven categories; one being less than primary school and 
 seven refl ecti ng an academic degree. Educati onal level 5 is comparable to 10-11 years of educati on.
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Cogniti ve domain Composed 
z-score (SEM)
p-value Impaired (%)
Episodic memory –0.48 (0.15) 0.003 11.4
Working memory 0.36 (0.16) 0.025 4.5
Executi ve functi oning 0.10 (0.097) 0.297 0
Fluency language –0.05 (0.11) 0.630 0
Speed of informati on processing –0.47 (0.12) <0.001 6.8
Table 2 Neuropsychological domain scores
Data of composed z-scores are expressed as means (SEM) based on normati ve data with a mean z–score of zero.
Impaired composed z-score is defi ned as z ≤ –1.65 (performance worse than 95% of the norm populati on).
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SF domain Mean z–score 
(SEM)
p–value Impaired (%)
Physical functi oning 0.15 (0.13) 0.233 6.2
Social functi oning –0.17 (0.15) 0.280 12.5
Role physical 0.10 (0.11) 0.348 6.2
Role emoti onal 0.03 (0.12) 0.779 6.3
Mental health 0.04(0.14) 0.788 7.8
Vitality 0.04 (0.14) 0.794 6.3
Pain 0.08 (0.11) 0.483 1.6
General health –0.26 (0.13) 0.049 9.4
Change in health –0.06 (0.13) 0.659 6.2
Table 3 Self reported quality of life
Data of composed z-scores are expressed as means (SEM) based on normati ve data with a mean z–score of zero.
Impaired composed z-score is defi ned as z ≤ –1.65 (performance worse than 95% of the norm populati on).
SMC Depression* Fati gueΔ
yes
80%
no
20%
p d yes
21%
no
79%
p d yes
36%
no
64%
p d
EM –0.65  0.31 0.02 –1.0 –0.63 –0.41 0.57 –0.2 –0.80 –0.30 0.12 –0.5
WM 0.26  0.66 0.33 –0.4 0.29  0.42 0.74 –0.1 0.18  0.46 0.40 –0.3
EF 0.01  0.46 0.08 –0.6 0.02  0.13 0.65 –0.2 –0.07  0.20 0.19 –0.4
VF –0.19  0.25 0.11 –0.7 –0.14 –0.00 0.64 –0.2 –0.39  0.13 0.02 –0.7
SP –0.53 –0.24 0.36 –0.4 –0.74 –0.40 0.24 –0.4 –0.78 –0.29 0.04 –0.7
Table 4 Associati on between subjecti ve memory complaints, depressive symptoms, 
 fati gue and objecti ve cogniti ve failure
All data are expressed as mean composed z–scores.
SMC = Subjecti ve memory complaints d = Cohen’s d eff ect size EM = Episodic memory 
WM = Working memory EF = Executi ve functi oning VF = Verbal fl uency 
SP = Speed of informati on processing
* Depressive symptoms, based on CESD ≥16
Δ Fati gue, based on CIS20R >27
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ABSTRACT
OBJECTIVES
To assess the prevalence of cancer and its characteristics in patients with ischemic stroke and 
to compare this with cancer prevalence in the general population.
METHODS
This is a multicenter cohort study with 2,736 patients presenting with ischemic stroke or TIA. 
The prevalence of cancer has been assessed by interview and verified by reviewing all medical 
records. In stroke patients with a history of cancer, we studied subtype of cancer and its 
treatment characteristics. We used the national database of the Netherlands Cancer Registry 
to calculate population based age and sex Standardized cancer Prevalence Ratio’s (SPR) for 
patients with ischemic stroke.
RESULTS
Cancer prevalence in ischemic stroke patients was 12 percent, corresponding with a SPR of 
1.2 (95%CI 1.0-1.3). Increased SPRs were observed for cancer of the central nervous system 
(SPR 18.2, 95%CI 9.0-27.4), head and neck (SPR 3.4, 95%CI 2.3-4.6), lower respiratory tract 
(SPR 2.4, 95%CI 1.5-3.3), and urinary tract (SPR 2.1, 95%CI 1.4-2.9), but not for other cancer 
types. Cardiovascular risk factors, stroke etiology, treatment and outcome were not different 
between patients with or without a history of cancer.
CONCLUSION
In stroke patients, the prevalence of cancer, most prominently cancer of the central nervous 
system, head and neck, lower respiratory and urinary tract, was higher than in the general 
population. Medical treatment for the prevention of stroke in cancer survivors deserves further 
study.
KEYWORDS
Cancer, Stroke, Epidemiology, Risk factors
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INTRODUCTION
Cancer and cardiovascular diseases are the two leading causes of morbidity and mortality 
worldwide.1An autopsy study in patients with cancer showed that 15% had evidence of 
prevalent cerebrovascular disease.2This co-occurrence of cancer and cerebrovascular disease 
may be explained by the high prevalence of both diseases in the general elderly population 
and by the share of highly prevalent population risk factors, particularly smoking. Cancer may 
also have a causal relationship with cerebrovascular disease by inducing a hypercoagulable 
state, nonbacterial thrombotic endocarditis and tumour compression of blood vessels. Direct 
and late toxicity of anti-cancer treatment, either radiotherapy (RT) related vasculopathy or 
chemotherapy related hypercoagulability could also be causative factors.2,3 A recent large 
study of cancer patients and matched controls showed a 3 month increased incidence of stroke 
in patients with lung, pancreatic and colorectal cancers.12 Within a sample of96 ischemic 
stroke patients with a known history of a cancer the most frequent types of prior cancer were 
lung (30%), brain (9%) and prostate (9%).11The population of long-term cancer survivors is 
growing and several studies have reported on the long-term vascular complications in these 
patients.6,90,91 Nevertheless studies on the prevalence and characteristics of cancer in a large 
cohort of patients presenting with ischemic stroke is lacking.
 The purpose of the current study was to investigate the prevalence of prior cancer in 
patients diagnosed with stroke in comparison with that in the general population in The 
Netherlands.
511640-L-bw-Wilbers
Processed on: 25-7-2017 PDF page: 104
104
LONG-TERM NEUROVASCULAR COMPLICATIONS IN CANCER PATIENTS
METHODS
From May 2007 onwards we recruited participants in a prospective multicenter cohort-study, 
called the String of Pearls Institute (PSI), a collaboration of the eight university medical centers 
(UMCs) in The Netherlands. Details of this study protocol have been described previously.92 
In short, a national stroke database with a standardized central infrastructure allowed uniform 
data collection and storage of biomaterials in patients presenting with a recent cerebrovascular 
disease. For the current study we included patients with ischemic stroke or Transient Ischemic 
Attack (TIA) as index event. All local Medical Ethical Committees of participating hospitals 
approved the study. The research was performed according to the principles of the Declaration 
of Helsinki and in accordance with the Medical Research Involving Human Subjects Act and 
codes on ‘good use’ of clinical data and biological samples as developed by the Dutch 
Federation of Medical Scientific Societies. (http://www.wma.net/en/10home/index.html) All 
patients provided written informed consent.
 We collected data on age, sex, cardiovascular risk factors (smoking, hypertension, 
hypercholesterolemia, diabetes mellitus), and presence or a history of atrial fibrillation, and 
previous cardiovascular events (ischemic stroke, TIA, acute myocardial infarction, and 
peripheral arterial disease), stroke severity by means of the National Institute of Health Stroke 
Scale (NIHSS) score at admission, and functional outcome at three months by the modified 
Rankin score.93 Etiology of stroke was classified according to the modified Trial of Org 10172 
in Acute Stroke Treatment (TOAST) criteria.55
 In the subset of patients with a history of cancer, we retrospectively collected information 
by reviewing the clinical records and contacting the general practitioner or treating oncological 
physician, on the type and stage of the cancer and treatment (type of chemotherapy, use of 
angiogenesis inhibitor, RT dosage and location). The interval between cancer and stroke was 
calculated in years.
 For comparison of our data we used information from the database of the Netherlands 
Cancer Registry, which registers the most important statistics on cancer in The Netherlands 
and is managed by the comprehensive cancer center the Netherlands (IKNL). Data collected 
included incidence, prevalence, survival, mortality and risk of different cancer types, as well 
as localization and morphological classification of tumours. Combining localization and 
morphology enables precise classification of diagnosis. The data in the Netherlands Cancer 
Registry is in accordance with the 10th edition of the International Classification for Diseases 
(ICD-10). Basal cell carcinoma and adenoma of the pituitary are not registered by the 
Netherlands Cancer Registry.
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DATA ANALYSIS
Stroke characteristics (cardiovascular risk factors, stroke etiology, treatment and outcome) in 
the patients with and without a history of cancer were compared after adjusting for age.All 
cancer characteristics were separately analyzed for patients who had active cancer or were ≤ 
5 years cancer free (short term cancer free patients ( CFP)) and those who had been cancer 
free > 5 years (long term CFP).
 We used Fisher’s test and Chi-squared test to assess unadjusted differences in proportions 
and a t-test to assess differences in mean values. In order to determine if any cancer type was 
more common amongst patients with stroke, we compared the 20-years prevalence of cancer 
diagnosis to the 20 years prevalence of diagnosis in the Dutch population for specific cancer 
localizations. We used data from the Netherlands Cancer Registry to calculate expected 
number of cases in our cohort, based on its age and sex distribution. We calculated 
Standardized Prevalence Ratio’s (SPR) by dividing the observed cancer number by the expected 
cancer number.
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RESULTS
We included 2,736 patients with a mean (SD) age of 65 (14) year of whom 59% were men. 
From these patients 321 (12%) had a history of cancer. Total number of cancers was 360. 
Patients with a history of cancer were significantly older (mean (SD) age 72 (12) years) than 
patients without is history of cancer (64 (14) years) (table 1). After adjusting for age, there 
were no significant differences in stroke characteristics between the patients with and the 
patients without a history of cancer. The majority of strokes were caused by large artery disease 
in both groups (39%).
CANCER CHARACTERISTICS
Among the 321 patients with stroke and a history of cancer, 13 different types of cancer were 
identified. The most common primary malignancy locations were male genital tract (16%), 
breast (16%), digestive tract (13%), urinary tract (10%) and head and neck cancer (9%) (Table 
2). 53% of the cancer patients were long CFP’s at time of stroke. From the short CFP’s, forty-two 
(26%) were treated with chemotherapy, versus 15% of the long term CFP’s (p-value < 0.02). 
Most frequently used chemotherapy included platinum based (45%) or alkylating (33%) in the 
short CFP’s and alkylating (65%) or antibiotic (55%) agents in the long CFP’s. Sixty-six (41%) of 
the short CFP’s versus eighty-two (47%) of the long CFP’s had received RT, most frequent for 
head and neck cancer. (Table 3)
 In the current cohort of stroke patients, increased SPRs were observed for cancer of the 
central nervous system (SPR 18.2, 95% CI 9.0-27.4), head and neck (SPR 3.4, 95% CI 2.3-4.6), 
lower respiratory tract (SPR 2.4, 95% CI 1.5-3.3) and urinary tract (SPR 2.1, 95% CI 1.4-2.9). 
Patients with CNS cancer showed a mean cancer-stroke interval of 9.2 years and 40% had an 
undetermined etiology of stroke. 57% of CNS patients had received RT with a mean (SD) dose 
of 55 (8) Gy. The subgroup of 23 patients with CNS cancer consisted mostly of glial tumours 
(n=8) and meningeoma (n=8; Appendix 2). Head and neck cancer patients had a mean cancer-
stroke interval of 7.2 years, TOAST classification showed mostly large artery disease (71%) and 
44% were current smokers. Patients with lower respiratory tract cancer had a mean cancer-
stroke interval of 6 years and 71% had stopped smoking. Patients with urinary tract cancer 
had a mean cancer stroke interval of 7.4 years and 62% were current or former smoker.
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DISCUSSION
The prevalence of cancer was higher in ischemic stroke patients than in the general population. 
In particular, central nervous system, head and neck, lower respiratory tract and urinary tract 
cancers were more prevalent in ischemic stroke patients than in the age and sex matched 
general population. Stroke etiology and outcome did not differ between ischemic stroke 
patients with and without a cancer history.
 The strongly increased SPR of CNS cancer in stroke patients has never been described 
before. The underlying pathology might partly be explained by a long-term RT induced 
intracranial vasculopathy. There are no prior reports about increased stroke risk in patients 
with meningeoma. The association of glioblastoma multiforme and ischemic strokes might 
be explained by postoperative complications, late complications of RT or a hypercoagulable 
state induced by the tumour or by vessel occlusion that is caused by an adjacent tumour.94,95 
In head and neck cancer, postradiation vasculopathy of the carotid artery is the most likely 
and best-known link with an increased risk ofstroke.6,49 The relatively high percentage of RT 
in this type of cancer and the relatively long mean latency period (9 years) between cancer 
and stroke support this association. Furthermore, head and neck, lower respiratory, urinary 
tract cancer and stroke have similar risk factors, in particular smoking. Most patients treated 
with chemotherapy had received platinum based or alkylating therapy, which are associated 
with a known increased risk of stroke.96 The most frequent cancer types in prior smaller 
retrospective studies in stroke patients included urogenital, breast, gastrointestinal, hemato-
logical and lung. 97 A high frequency of stomach cancer was observed in a retrospective 
case-control study in stroke patients in Korea. 98 We did not find an increase prevalence of 
stomach cancer, however cancer types distributions differ around the world. A recent study 
among 327,389 pairs of cancer patients and matched controls showed a 3 month increased 
incidence of stroke in patients with lung, pancreatic and colorectal cancers.12 They restricted 
their sample to people with the most common types of cancer (breast, colorectal, lung, and 
prostate cancers and further added pancreatic cancer) and assessed the 3 and 12 months 
stroke incidences compared to a reference population. We studied the more long term relati-
onship between all subtypes of cancer and stroke by assessing the prevalence of cancer within 
a stroke population compared to that in the general population.
 Furthermore, we found that stroke characteristics were not different between patients 
with or without a cancer history, which is in line with prior smaller retrospective analyses.97-99
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Our study is, the first and largest multicenter study in stroke patients that combined patient, 
stroke and cancer characteristics. Furthermore, it is the first study that compares these charac-
teristics with that in the general population. Since cancer types distributions are different over 
the world and depend on age and sex, it was important that we were able to compare the 
prevalence of the different cancer types in our stroke cohort with that from the same source 
population, stratified on age and sex.
 Our study has some limitations. Patients with a history of cancer potentially have a higher 
likelihood to be diagnosed with stroke due to long-term surveillance with lower threshold to 
do more extensive evaluations. However, we did not observe differences in stroke subtypes 
or severity between patients with and without a cancer history. If this bias had occurred one 
would expect more relatively mild strokes in those with a cancer history. Furthermore, patients 
with a history of cancer could have been more often referred to university medical centers 
because of their cancer history. This is not very likely because in the Netherlands almost all 
hospitals provide acute stroke care and patients are referred to the nearest hospital. 
Furthermore, we did not observe differences between participating hospitals with large 
specialized oncology departments and those without. The retrospective identification and 
verification of cancer cases may have resulted in some misclassification. However, it is unlikely 
that cancer is underreported by the patients themselves because of the impact of this disease. 
Furthermore the systematic registration of cancer diagnosis and treatment makes it unlikely 
that false positive cases are included. Comparison of cancer frequencies in a stroke cohort 
with that in the general population does not take into account that among the latter stroke 
was not excluded. This would result in an underestimation of risk ratios if compared with a 
stroke-free population. Due to our study design we were not able to calculate absolute stroke 
risks for the different types of cancer and cancer treatments.
 Since the group of cancer survivors increases, it is clinically relevant to define types of cancer 
associated with an increased stroke risk and its associated specific risk factors. This could be 
helpful in finding potentially modifiable risk factors to develop prevention guidelines and to 
optimally inform patients.
 In conclusion, we showed an overall increased prevalence of cancer and particularly specific 
types of cancer in stroke patients as compared to the general population. Cancer types that 
showed an increased prevalence were, CNS, head and neck, lower respiratory and urinary 
tract cancers. Stroke characteristics were not different between patients with and without 
cancer. These findings may have clinical relevance given that at least a part of this association 
is driven by factors potentially amenable to treatment. Further studies should address whether 
treatment of cardiovascular risk factors in survivors of CNS, head and neck, lower respiratory 
and urinary tract cancers, prevents stroke.
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FIGURES AND TABLES
Table 1 Demographics and characteristi cs of pati ents with (n=321) and without (n=2415) 
 a history of cancer at the ti me of diagnosis of ischemic stroke 
Pati ents with stroke 
and cancer history
Pati ents with stroke 
without cancer history
p-value*
n=321 (12%) n=2415 (88%)
Demographics
Men 186 (58) 1435 (59) 0.77
Age, mean (SD) 72 (12) 64 (14) <0.001
Risk factors
Smoking
Never 113 (38) 847 (37)
Stopped > 6 months 123 (41) 761 (33)
Stopped < 6 months 8 (3) 48(2)
Current 57 (19) 637 (28)
Hypertension 190 (59) 1271 (53) 0.85
Hypercholesterolemia 116 (37) 831 (35) 0.49
Diabetes 60 (19) 376 (16) 0.86
Atrial fi brillati on 53 (17) 286 (12) 0.72
Past arterial events
IS/TIA 98 (32) 655 (29) 0.97
AMI 43 (14) 259 (11) 0.82
PAD 28(9) 180 (8) 0.92
Stroke characteristi cs
Durati on < 24 hours 58 (19) 419 (18) 0.57
TOAST 0.05
LAD 84 (39) 645 (39)
CE 42 (19) 222 (14)
SVD 30 (14) 291 (18)
Other 62 (28) 480 (29)
NIHSS, mean (SD) 4 (5) 4 (5) 0.94
Treatment
IV Thrombolysis 44 (16) 386 (19) 0.29
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(cont. table 1)
Data are expressed as numbers (percentage, complete case analysis), unless otherwise indicated.
AMI = Acute myocardial infarct PAD = Peripheral arterial disease IS = Ischemic stroke 
TIA = Transient ischemic att ack TOAST = Trial of Org 10172 in acute stroke treatment 
LAD = Large artery disease CE = Cardio embolism SVD = Small vessel disease 
NIHSS = Nati onal Insti tute of Health Stroke Scale MRS = Modifi ed ranking scale
* p-value for diff erence adjusted for age
Pati ents with stroke 
and cancer history
Pati ents with stroke 
without cancer history
p-value*
n=321 (12%) n=2415 (88%)
Outcome at three months (MRS) 0.20
0 64 (28) 589 (31)
1 64 (28) 500 (28)
2 39 (17) 400(22)
3 27 (12) 183 (10)
4 19(8) 81 (5)
5 2(1) 24(1)
6 13(6) 56 (3)
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Table 2 Absolute and relati ve frequencies of prevalent cancer subtypes 
 at the ti me of ischemic stroke diagnosis
Data are expressed as absolute numbers (percentage).
Type of cancer Total Cancer free
≤5 years
Cancer free
>5 years
n=360 n=171 n=189
Male genital tract 59 (16) 36 (21) 23 (12)
Breast 57 (16) 16 (9) 41 (22)
Digesti ve tract 48 (13) 23 (14) 25 (13)
Urinary tract 35 (10) 19 (11) 16 (9)
Head and neck 33 (9) 14 (8) 19 (10)
Blood, lymph and bone marrow 28 (8) 14 (8) 14 (7)
Lower respiratory tract 27 (8) 15 (9) 12 (6)
Skin 26 (7) 10 (6) 16 (9)
Central nervous system 20 (6) 16 (9) 4 (2)
Female genital tract 15 (4) 4 (2) 11 (6)
Endocrine 7 (2) 3 (2) 4 (2)
Bone and soft  ti ssue 4 (1) 1 (1) 3 (2)
Eye and orbit 1 (0) 0 (0) 1 (1)
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Table 3 Characteristi cs of cancer treatment in an ischemic stroke populati on
Data are expressed as number and percentage (complete case analysis), unless otherwise indicated.
Valid percentages do not add up to 100% due to overlap and multi ple treatments.
P-value for diff erence between cancer free ≤5 years and cancer free >5years by chi square test 
and for diff erences in RT dose by independent Sample T-test.
Treatment characteristi cs Total Cancer free
≤5 years
Cancer free
>5 years
p-value
n=360 n=171 n=189 CAU
Chemotherapy 68 (20) 42 (26) 26 (15) 0.02
Alkylati ng 26 (44) 13 (33) 13 (65) 0.04
Plati num based 21 (36) 17 (45) 4 (20) 0.12
Anti bioti c 17 (29) 6 (15) 11 (55) 0.004
Topoisomirase inhibitor 12 (21) 9 (24) 3 (16) 0.73
Anti  metabolite 9 (16) 7 (18) 2 (11) 0.70
Anti -mitoti c 9 (16) 3 (8) 6 (30) 0.07
Methotrexate 6 (11) 3 (8) 3 (16) 0.65
Local 7 (13) 4 (11) 3 (16) 0.68
Other 20 (34) 14 (36) 6 (30) 0.87
Other systemic treatments
Rituximab 7 (12) 6 (16) 1 (5) 0.48
Tyrosin kinase inhibitor 3 (5) 3 (8) 0 (0) 0.53
Angiogenesis inhibitor 7 (2) 5 (3) 2 (1) 0.39
Radiotherapy 148 (44) 66 (41) 82 (47) 0.29
Locati on radiotherapy 0.06
Head or neck 54 (37) 25 (39) 29 (35)
Chest 41 (28) 12 (19) 29 (35)
Other 52 (35) 28 (43) 24 (29)
Dose (Gy), mean (SD)
Head or neck 52 (15) 53(16) 50(15) 0.51
Chest 51 (11) 52 (14) 50(9) 0.69
Other 50 (30) 40 (24) 62(33) 0.08
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Type of cancer Observed 
number
Expected 
number
SPR 95% CI
Male genital tract* 56 54 1.0 0.8–1.3
Breast* 43 42 1.0 0.7–1.3
Digesti ve tract 38 46 0.8 0.6–1.1
Urinary tract 31 15 2.1 1.4–2.9
Head and Neck 29 9 3.4 2.3–4.6
Blood, lymph and bone marrow 23 18 1.3 0.8–1.8
Lower respiratory tract 26 11 2.4 1.5–3.3
Skin 21 38 0.6 0.3–0.8
Central nervous system 15 1 18.2 9.0–27.4
Female genital tract* 5 12 0.4 NA
Bone and soft  ti ssue 2 2 1.1 NA
Endocrine 4 1 2.7 NA
Any cancer 273 238 1.2 1.0–1.3
Table 4 Standardised 20–years Prevalence Rati o of cancer subtypes in 
 ischemic stroke pati ents
SPR = Standardized prevalence rati o NA = Not applicable
Expected number calculated from the age specifi c 20 years prevalence in the Dutch populati on 
(source: Dutch Cancer Registrati on, www.cijfersoverkanker.nl)
Cancer diagnosis > 20 years before 2011 were excluded in these analysis.
* SPR for male genital tract, female genital tract and breast cancer was calculated for men only 
 and women only respecti vely. 95% confi dence intervals for cancer types with low prevalence 
 (i.e. <5 cases) could not be calculated.
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SUPPLEMENTARY
The Dutch String of Pearls Stroke Study Group consists of:
Nederkoorn, PJ, Department of Neurology, Academic Medical Centre, Amsterdam, the 
Netherlands
van Dijk EJ, Department of Neurology, Donders Insti tute for Brain, Cogniti on and Behaviour, 
Centre for Neuroscience, Radboud University Medical Centre, Nijmegen, the Netherlands
Koudstaal PJ, Department of Neurology, Erasmus Medical Centre, Rott erdam, the Netherlands
Luijckx GJ, Department of Neurology, University Medical Centre Groningen, University of 
Groningen, the Netherlands
van Oostenbrugge RJ, Department of Neurology, Maastricht University Medical Centre and 
Cardiovascular Research Insti tute Maastricht (CARIM), Maastricht, the Netherlands
Visser MC, Department of Neurology, VU Medical Centre, Amsterdam, the Netherlands
Wermer MJ, Department of Neurology, University Medical Centre Leiden, the Netherlands
Ruigrok YM, University Department of Neurology and Neurosurgery, Rudolf Magnus Insti tute 
of Neuroscience, University Medical Centre Utrecht, Utrecht, the Netherlands
Siegerink B, Department of epidemiology, Leiden University Medical Centre, the Netherlands, 
Centre for stroke research Berlin, Charite Universitätsmedizin Berlin, Germany
Algra A, University Department of Neurology and Neurosurgery, Rudolf Magnus Insti tute of 
Neuroscience, University Medical Centre Utrecht, Utrecht, the Netherlands
Kappelle LJ, University Department of Neurology and Neurosurgery, Rudolf Magnus Insti tute 
of Neuroscience, University Medical Centre Utrecht, Utrecht, the Netherlands
Supplement  1 Study group
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Pati ents Gender Cancer Interval 
(yr)
RT Chemo
1 F Ependymoma 3 Yes No
2 F HGG 2 Yes No
3 F HGG 4 Yes No
4 F Meningeoma 0 No No
5 F Hemangioblastoma 2 No No
6 M HGG 1 Yes Yes
7 M Meningeoma 3 Yes No
8 M Ependymoma 17 Yes No
9 M Meningeoma 6 Yes No
10 M Meningeoma 7 No No
11 M Cerebello-ponti n angle 0 No No
12 M Meningeoma 1 No No
13 M Meningeoma 13 No No
14 M Meningeoma No No
15 M Cerebello-ponti n angle 11 No No
Supplement  2 Characteristi cs of pati ents with CNS cancer
F = Female M = Male HGG = High Grade Glioma
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ABSTRACT
BACKGROUND
Head and neck cancer (HNC) patients treated with radiotherapy (RT) are at increased risk of 
stroke as a late complication. We evaluated the long-term cost effectiveness (CE) of a one-time 
screening and treatment strategy for cardiovascular risk factors in HNC patients treated with 
RT. This strategy was called PREvention of VAScular disease in Cancer (PREVASC).
METHODS
We used Markow and Monte Carlo computer simulation models to estimate the CE of the 
PREVASC strategy, which we compared with current care as usual (CAU). CE was modeled for 
a period of 10 and 20 years. Sensitivity analyses were performed for predefined factors.
RESULTS
The estimated CE ratio for PREVASC and CAU was €222 and €199 per quality adjusted life year 
(QUALY) gained at 10 years and €434 and €353 per QUALY gained at 20 years of follow-up. 
After a follow-up of 10 and 20 years respectively, the threshold of PREVASC being more cost 
effective than CAU was at a relative risk reduction (RRR) of strokeof > 48% and >20%, costs of 
stroke > 113K and >€47K and costs of PREVASC irrespectively and < 343€/patient. Since 
predicted RRR of PREVASC was 28%, predicted costs of stroke €55K and predicted costs of 
PREVASC €200/patient, PREVASC is likely to be more cost-effective than CAU only at 20 years 
follow-up.
CONCLUSION
A one-time screening and treatment strategy to prevent strokes in newly diagnosed HNC 
patients treated with RT is not a cost effective approach.
KEYWORDS
Head and neck cancer, Cancer, cerebrovascular disease, cardiovascular risk factors, prevention, 
survivors, cost-effectiveness
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BACKGROUND
Cancer and cardiovascular disease are the leading causes of morbidity and mortality 
worldwide.1 Due to increased cancer survival rates, the population of long-term survivors is 
growing and hence the absolute number of long-term complications of its treatment as well. 
Several recent studies reported about a increased risk of cardiovascular diseases in survivors 
of specific forms of cancer, like patients treated for breast cancer and Hodgkin’s disease.50,100 
Preexisting cardiovascular risk factors even further increases the risk of cardiovascular 
disease.100 With increasing number of cancer survivors, strategies to prevent long-term cancer 
related complications become more important. Radiotherapy (RT) induced carotid artery 
vasculopathy and related increased risk of stroke is a known long-term complication of head 
and neck cancer (HNC) treatment. 5,6,91 In a prospective follow-up study of 65 HNC patients 
on average 7 years after RT, we earlier described a significant increase of vessel wall pathology 
66 and a six-fold increased risk of stroke when compared to the age matched general 
population.72 The vast majority of these patients had one or more cardiovascular risk factors 
before RT. Although there are several studies pointing to the importance of these long-term 
complications, to date preventive guidelines are lacking. Therefore, we developed a prevention 
strategy called PREvention of Vascular disease in Cancer (PREVASC). It consisted of a one-time 
screening and treatment of cardiovascular risk factors in newly diagnosed HNC patients treated 
with RT with the primary aim to prevent stroke.
 The purpose of the present study was to assess incremental CE of PREVASC compared to 
care as usual (CAU).
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METHODS
INTERVENTION
PREVASC consisted of a one-time screening and treatment of cardiovascular risk factors in 
newly diagnosed HNC patients treated with RT. The goal was to prevent future ischemic stroke. 
The CE of PREVASC was compared to CAU, that consisted of no counseling. The PREVASC 
strategy consists of assessment of current and past smoking habits, physical activity, fasting 
glucose and cholesterol levels, blood pressure and Body Mass Index. Further an electrocar-
diogram was obtained to assess atrial fibrillation, ischemic changes and left ventricular 
hypertrophy. The result was a structured and evidence-based advice for patients and their 
general practitioners based on widely used AHA guidelines for primary prevention of cardio-
vascular disease 101,102.
SOURCES OF DATA
Data for the model were obtained from a literature review, the database of the Dutch cancer 
registry, the National Institute for Public Health and the Environment and data from a 
prospective multicentre cohort study, designed to investigate the long-term vascular and 
cerebral complications after RT of the neck 66. (Table 1) The model is based on a prior cohort 
study, showing a increased risk of stroke on average 7 years after RT in HNC patients.66 The 
Medical Ethics Review Committee region of Arnhem-Nijmegen approved the study (NL 
41008.091.12).
 In this cohort of 65 HNC survivors 68% had one or more other cardiovascular risk factors at 
baseline (before RT). Ten years survival rates of HNC patients were obtained from the database 
of the Dutch Cancer Registry and 20 years survival rates were extrapolated using mortality rates 
of the general population.103 104 Mortality rates after stroke were obtained from the national 
institute for public health and the environment. 105 Stroke risk in 10 and 20 years survivors of 
HNC were extrapolated from a prior retrospective study. 6 The expected risk reduction of stroke 
achieved by the PREVASC was predicted by the relative risk of stroke after treatment of cardio-
vascular risk factors. 106 Total PREVASC cost per patient was calculated as the sum of staff cost 
(physician and registered nurse), cost of supplementary examination (laboratory, ECG) and 
overhead expenditure. (Table 2) Costs of a yearly visit by the general practitioner were obtained 
from the Dutch Health Care Authority. 107 Mean health care costs of a stroke until dead were 
obtained from literature. Because this source was 15 years old, we took into account an inflation 
of 1%. 108 These costs included nursing home costs. Costs related to gain of working abilities 
were not included. Costs of treatment with first choice antihypertensive medication or a statin 
were gained from the National Health Care Institute. 109 Health related quality of life weights 
for HNC and stroke patients were based on earlier data. 110,111 Finally, we corrected for 
decreasing value of costs and utilities with longer follow-up period. 112
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MODEL
A Markow decision model was constructed with two treatment strategies: PREVASC and CAU. 
(Figure 1) Patients were classified as increased risk (one or more cardiovascular risk factors) 
or standard risk (no cardiovascular risk factors) and three outcome states were defined: no 
stroke or death, stroke and dead. A Monte Carlo computer simulation model was used to 
estimate the CE of PREVASC and CAU. The model simulated the course of events in the two 
treatment strategies over a 10 and 20 years follow-up period. Participants consisted of a 
hypothetical cohort of 1000 HNC patients recently treated with RT.
SENSITIVITY ANALYSIS
In the sensitivity analysis, we examined variations in all important variables in our base-case 
analysis, including risk reduction of stroke by PREVASC, costs of stroke and costs of PREVASC.
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RESULTS
COST-EFFECTIVENESS
Total health care costs per patient at 10 and 20 years follow-up were €1223 and €3721 for 
PREVASC and €1096 and €3876 for CAU. PREVASC compared to CAU resulted in an incremental 
increase of €127 per patient and an increase of 0.004 QALY per 10 years of follow-up (table 
3). PREVASC compared to CAU resulted in an incremental decrease of €154 per patient and 
increase of 0.02 QALY per 20 years of follow-up. The estimated CE ratio for PREVASC and CAU 
was €222 and €199 per quality adjusted life year (QUALY) gained at 10 years and €434 and 
€353 per QUALY gained at 20 years of follow-up. A scatter plot of the bootstrap derived joint 
distribution of cost and effectiveness differences is shown in figure 2 and the associated CE 
acceptability curve is plotted in figure 3. The scatter plot shows the mean differences in costs 
and outcomes from the data using 1000 bootstrap replicates. After 20 years follow-up, 35% 
of the dots are in the north-quadrant which indicates that PREVASC is in 35% less expensive 
and more effective. A total of 65% of the dots are in the south quadrant, indicating that 
PREVASC is less expensive in 65%. The cost-effectiveness acceptability curves indicate the 
probability of PREVASC being more cost effective than CAU with variable willingness to pay. 
It revealed that PREVASC was always more CE than CAU after 20 years of follow-up.
SENSITIVITY ANALYSIS
The sensitivity analysis showed that risk of stroke and risk reduction of PREVASC were 
influential on the incremental effect of PREVASC. (figure 4)After a follow-up of 10 years the 
threshold of PREVASC being more CE than CAU was at a Relative risk reduction RRR of stroke 
>48%. After 20 years of follow-up this threshold was >20%. Since predicted RRR of PREVASC 
was 28%, PREVASC is more CE than CAU after 20 years follow-up. After a follow-up of 10 years 
the threshold of PREVASC being more CE than CAU was at a cost of stroke > €113K. After 20 
years of follow-up this threshold was > 47K. Since predicted cost of stroke was €65K, PREVASC 
will likely not generate extra health care costs after a follow-up of 20 years.After a follow-up 
of 10 years PREVASC is always more expensive irrespective of the costs of first visit PREVASC. 
After 20 years of follow-up the threshold of PREVASC being more CE than CAU was at costs of 
PREVASC < €342. Since predicted cost of first visit PREVASC was €116 per patient in the 
Netherlands, PREVASC is more CE than CAU after a follow-up of and 20 years.
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DISCUSSION
The current study showed that a one-time screening and treatment strategy to prevent strokes 
in newly diagnosed HNC patients treated with RT is not a cost effective approach over a 20 year 
follow-up period. This is the first study describing the CE of a preventive strategy in long-term 
survivors of HNC. A strength of our study is that we took several uncertainties and not directly 
visible costs into account. There are some potential under and overestimating factors.
FACTORS THAT POTENTIALLY UNDERESTIMATE THE CE
The conservative character of the model could have resulted in an underestimation of the 
CE.Firstly, we only included the directly health related costs and not the costs associated with 
unemployment after a stroke. The sensitivity analysis showed that when the health care costs 
of stroke exceeded €113K, PREVASC would be cost-effective even after a follow-up period of 
10 years. Taking the costs associated with unemployment into account as well, costs of stroke 
will exceed the €113K threshold by far and the CE of PREVASC will increase remarkably with 
time. Secondly, cardiovascular risk reduction in this group of patients with a burden of 
modifiable cardiovascular risk factors probably will not only prevent strokes, but also non-ra-
diotherapy related cardiovascular diseases (acute myocardial infarction and peripheral arterial 
disease), COPD, and diabetes. These additional risk reductions and the consequent cost 
reduction were not taken into account in the current model. However, taking these extra cost 
reductions into account as well, preventable costs will exceed the €113K threshold by far and 
the CE will increase further.
FACTORS THAT POTENTIALLY OVERESTIMATE THE CE
Firstly, assumptions on a long-term view of 10 and 20 years are always difficult because of 
continuously changing health- and socio-economic circumstances. However, we tried to correct 
for this potential problem by taking into account the variability of appreciation of costs and 
QUALY’s over time. Secondly, loss of patient’s compliance over a long time period. Since clinical 
trials report average adherence rates of only 43% to 78% among patients receiving treatment 
for chronic conditions 113 and adherence is inversely proportional to frequency of dosage 114, it 
is important to correct for compliance. We expected to increase the adherence rate by including 
a yearly follow-up visit by the general practitioner and dosing frequency of medication of only 
once a day. The sensitivity analysis showed, that PREVASC was more CE than CAU at a RRR of 
stroke >20% after 20 years follow up. The predicted RRR of PREVASC was 28% and therefore 
above this threshold. Thirdly, we did not correct for costs in terms of money and QUALYs of 
potential side effects related to the treatment of cardiovascular risk factors. However, we do not 
expect seriously adverse events. Since there are no guidelines for primary prevention in this 
specific group of long-term HNC survivors, we extrapolated the widely used existing guidelines 
for primary prevention in patients with increased risk of cardiovascular diseases. 101,102
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CONCLUSION
In conclusion, the current study showed that a one-time screening and treatment strategy to 
prevent strokes in newly diagnosed HNC patients treated with RT was not a cost effective 
approach. Physicians should be aware of these potential long-term complications and patients 
should be counseled. In future more extensive preventive strategies have to be developed 
and implemented in the standard of care.
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FIGURES AND TABLES
Figure 1 Markow model
HNC = Head and neck cancer PREVASC = Preventi on of vascular disease in cancer 
CAU = Care as usual IR = increased risk, defi ned as one or more cardiovascular risk factors 
SR = standard risk, defi ned as no cardiovascular risk factors
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Range Esti mates Range Source
Probabiliti es
No show PREVASC 0.25 0.13–0.43
Show PREVASC 1-P no show 
Second visit 0.30 0.17–0.44
IR pati ent 0.68 0.52–0.82 Wilbers (8) 
SR pati ent 1-P IR pati ent
Stay in SR group/year 0.80 (0.04) 0.64–0.93
Dead, cumulati ve NCR (10)(11)
10 yrs aft er HNC 0.42
20 yrs aft er HNC 0.54
Stroke in IR, cumulati ve Dorresteijn (4)
10 yrs aft er HNC 0.03
20 yrs aft er HNC 0.20
Stroke in SR pati ent 0.5 x P stroke IR 
Dead aft er stroke* 0.22 0.12–0.36 RIVM (12)
RR stroke PREVAC vs CAU 0.72 0.50–0.95 Hackam (13)
Discount Rate (%)
Costs 4
Uti liti es 2
Costs
Stroke (€) ± 65K 58–72K Niessen (15)
PREVASC
First visit (€) 116 Local costs
Second visit (€) 66
General Practi ti oner (€/year) 20 DHA (14)
Uti liti es, QUALYs
HNC pati ent 0.84 0.62–0.96 Ramaekers (17)
Stroke pati ent 0.66 0.42–0.84 Fernandez (18)
Table 1 Summary of variables
P = Probability IR = Increased risk, defi ned as ≥ 1 cardiovascular risk factor(s) SR = Standard risk, defi ned as 
< 1 cardiovascular risk factor HNC = Head and neck cancer PREVASC = Preventi on of vascular disease in cancer 
outpati ent clinic CAU = Care as usual NCR = Netherlands Cancer Registry RIVM = Nati onal insti tute for public 
health and the environment (ministry of health, welfare and sport) DHA = Dutch Health care Authority
* Mortality aft er stroke, defi ned as probability of death within the fi rst 28 days aft er cerebral infarcti on. 
 ± Costs of stroke, defi ned as mean health care costs aft er a cerebral infarcti on unti l dead. α Medicati on costs 
 are the sum of costs lisinopril 10mg once a day and simvastati n 40mg once a day and are only calculated 
 taken into account in the PREVASC increased risk pati ents.
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Total (€)
First visit
Staff  costs (nurse (1.5h), physician (0.08 h)) 72.51
Material costs 19.21
Overhead (33%) 23.90
Total ﬁ rst visit 115.54
Second visit
Staff  costs (Nurse (1h)) 35.07
Material costs 19.21
Overhead (33%) 11.57
Total second visit 65.85
Total 181.39
Table 2 Costs PREVASC
Total PREVASC costs per pati ent, calculated as the sum of staff  costs, 
costs of supplementary examinati on and overhead expenditure
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Ten years 
aft er follow-up
Twenty years 
aft er follow-up
PREVASC CAU* PREVASC* CAU
Costs (€) 1223 1096 3721 3876
Eff ecti veness (QALY) 5.509 5.505 8.584 8.565
CE (€/QALY) 222 199 434 353
Incremental
Costs (€) +127 –127 -154 +154
Eff ecti veness (QALY) +0.004 –0.004 +0.019 –0.019
CE (€/QALY) –28 542 +28 542 +8147 –8147
Table 3 Base case results
PREVASC = Preventi on of vascular disease in cancer outpati ent clinic 
CAU = Care as usual CE = Cost eff ecti veness
* Dominati ng strategy
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Figure 2a Incremental cost eff ecti veness, PREVASC vs. care as usual
Scatt er plot of the esti mates of diff erences in costs (y-axis) and eff ecti veness (x-axis) as found by a Monte Carlo 
simulati on, based on 1000 runs (A so called ICE plane). In case of a follow up ti me of twenty years in the Markov 
Model, 65% of the runs ends in the south part (third and fourth quadrant), which means that in 65% of the runs 
PREVASC is cheaper than CAU. In case the Willingness To Pay (WTP) equals 0, this is the part in which the PREVASC 
is considered to be cost-eff ecti ve compared to CAU. So this simulati on shows that the probability PREVASC will be 
cost-eff ecti ve equals 65% and the probability CAU will be cost-eff cti ve equals 35%, in case WTP=0 euro’s.
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Figure 3 Cost eff ecti veness acceptability curve aft er ten years of follow up
PREVASC = Preventi on of vascular disease in cancer outpati ent clinic CAU = Care as usual
The acceptability curve shows the probability for both strategies to be cost eff ecti ve as a functi on of the 
willingness to pay (WTP). Regardless of the WTP the fi gure shows, that in case of twenty year follow-up, there 
is always a slightly higher probability that PREVASC will be cost eff ecti ve than that CAU will be cost eff ecti ve.
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Figure 4a One way sensiti vity analysis on RR of stroke PREVASC versus CAU
PREVASC = Preventi on of vascular disease in cancer outpati ent clinic CAU = Care as usual
The acceptability curve shows the probability for both strategies to be cost eff ecti ve as a functi on of the 
willingness to pay (WTP). Regardless of the WTP the fi gure shows, that in case of twenty year follow-up, there 
is always a slightly higher probability that PREVASC will be cost eff ecti ve than that CAU will be cost eff ecti ve.
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Figure 4b One way sensiti vity analysis on RR of stroke PREVASC versus CAU
PREVASC = Preventi on of vascular disease in cancer outpati ent clinic CAU = Care as usual
Aft er a follow-up of ten years the threshold of PREVASC being more CE than CAU was at a cost of stroke > €113K. 
Aft er twenty years of follow-up this threshold was > €47K. Since predicted cost of stroke was €65K , PREVASC is 
more CE than CAU aft er a follow-up of twenty years. Again the eff ect is always bett er for PREVASC than for CAU, 
so it is suffi  cient to look at the costs.
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Figure 4c One way sensiti vity analysis on costs of PREVASC
PREVASC = Preventi on of vascular disease in cancer outpati ent clinic CAU = Care as usual
Aft er a follow-up of ten years PREVASC is always more expensive irrespecti ve of the costs of PREVASC. 
Aft er twenty years of follow-up the threshold of PREVASC being more CE than CAU was at costs of PREVASC < €342. 
Since predicted costs of fi rst visit PREVASC was €116, PREVASC is more CE than CAU aft er a follow-up of twenty 
years. Again the eff ect is always bett er for PREVASC than for CAU, so it is suffi  cient to look at the costs.
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SUMMARY
The main findings of this thesis are:
1. In patients with head and neck cancer treated with radiotherapy:
1.1. Intima Media Thickness of the carotid artery measured by ultrasonography does 
not increase over the course of the first two years.
1.2. Intima Media Thickness of the carotid artery measured by ultrasonography 
increases over the course of the first seven years.
1.3. The irradiated carotid arteries show more vessel wall thickening than the non-irra-
diated carotid arteries on average seven years after radiotherapy without a 
difference in MR signal of the vessel wall.
1.4. The incidence rate of ischemic stroke appears higher than in the general 
population in the first seven years after radiotherapy (about six-fold).
1.5. Cognitive function is worse than in the general population seven years after 
radiotherapy.
1.6. Worse cognitive function is associated with subjective complaints, fatigue and 
cerebral infarcts on MRI, but not with depressive symptoms, presence of white 
matter lesions and a lower brain volume.
2. Overall cancer prevalence in ischemic stroke patients in the Netherlands is 12%, which 
is about 20% more than in the general population.
3. Ischemic stroke patients, when compared with the general population have increased 
standardized prevalence ratios of cancer of the central nervous system, head and neck, 
lower respiratory and urinary tract.
4. A one-time screening and treatment of vascular risk factors in newly diagnosed head 
and neck cancer patients is not cost-effective.
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RADIOTHERAPY INDUCED NEUROVASCULAR COMPLICATIONS IN HEAD AND NECK CANCER
Over the last decade, attention for long-term complications in cancer survivors has been 
growing. Most studies assessing radiotherapy induced carotid vasculopathy and ischemic 
stroke in head and neck cancer survivors were retrospective in design and mainly focused on 
carotid intima media thickness and ischemic stroke.5,6,91 However, the natural course and 
imaging characteristics of this radiotherapy-induced vasculopathy were not clear. Furthermore, 
potential clinical consequences of this carotid wall pathology, like vascular white matter lesions 
or cognitive deficits were not studied before.
 Therefore, we started a long-term prospective follow-up study in head and neck cancer 
patients treated with radiotherapy on baseline.66 This study showed that within the course 
of the first two years intima media thickness of the irradiated carotid arteries was not 
increased, whereas after seven years it was. The prospective design of our study added to the 
understanding of the natural course of radiotherapy-induced vasculopathy by showing that 
this process takes several years to develop visual vascular wall changes on ultrasonography. 
As a consequence of the prospective study design, we assessed the beginning stage of these 
vessel wall changes and therefore found relative mild vessel wall thickening.
 The results of the MRI study were in line with the results of the ultrasonography study and 
showed vessel wall thickening of the irradiated carotid arteries after seven years. Advantages 
of MRI above ultrasonography were the possibility to study a larger part of the carotid artery 
and to study the composition of plaques. Due to the relatively mild vascular thickening in the 
first years after radiotherapy it was however more difficult to analyze plaques than in more 
advanced atherosclerosis. In future studies, longer follow-up, the use of a dedicated neck coil 
and contrast enhanced pictures could increase the distinctive character of the MRI to detect 
vessel wall changes.71
 We hypothesized that radiotherapy induced carotid artery changes could result in vascular 
white matter lesions of the brain with consequently cognitive deficits. We showed that head 
and neck cancer patients had cognitive deficits seven years after radiotherapy, which were 
related to subjective complaints and fatigue and also to vascular white matter lesions and 
ischemic strokes on MRI. In fact, these cognitive deficits were multi-factorial influenced. To 
what extend the vascular white matter lesions were a consequence of the relatively mild 
carotid artery wall thickening or probably more logical influenced by the co-occurrence of 
other vascular risk factors, it not clear. To study this relationship in more detail, a larger sample 
of patients is mandatory.
SUMMARY / GENERAL DISCUSSION
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CANCER PREVALENCE IN STROKE PATIENTS
Cancer patients are at increased risk of ischemic stroke. Prior studies, mostly from the group 
of the Memorial Sloan Kettering Cancer Center in New York focused on the risk of stroke in 
patients with active cancer. In contrast to our study the design of their study was focused on 
the incidence of stroke in patients with active cancer instead of the prevalence of cancer in 
stroke patients. This difference in design is a plausible explanation for the observed discre-
pancies with our results. They showed that the most frequent types of active cancer associated 
with concomitant stroke were lung, brain and prostate.11 Furthermore, they showed an 
increased incidence of stroke in patients with lung, pancreatic and colorectal cancers during 
a three-month follow-up.12 Large epidemiologic studies assessing the relation between 
ischemic stroke and long-term survivors of cancer are lacking. The start of a prospective 
multicenter cohort-study, called the String of Pearls Initiative (PSI), a collaboration of the eight 
university medical centers (UMCs) in The Netherlands in 2007, made it possible to recruit a 
large group of 2736 patients presenting with ischemic stroke.92 Within a cohort of 321 survivors 
of cancer we were able to assess types of cancer associated with ischemic stroke especially 
on the long-term. We showed increased prevalence of central nervous system, head and neck, 
lower respiratory and urinary tract cancer in patients presenting with ischemic stroke. This 
prevalence approach is an efficient way to study stroke in long-term survivors of cancer. The 
underlying etiologies of cancer types associated with a long-term risk of ischemic stroke are 
different from those associated with short-term risk of ischemic stroke. The most obvious 
explanation for a relation between central nervous system and head and neck cancer on the 
one hand and the late occurrence of stroke on the other is radiotherapy induced carotid artery 
vasculopathy. Lower respiratory tract, urinary tract, head and neck cancer and ischemic stroke 
share smoking as an important risk factor. Causal pathways in active cancer patients with 
ischemic stroke are more related to direct cancer effects (as hypercoagulability and non-bac-
terial endocarditis) or chemotherapy related toxicity.
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PREVENTION OF VASCULAR DISEASE IN HNC PATIENTS
The studies in this thesis showed that particular groups of long-term cancer survivors have an 
increased risk of vessel wall changes and of ischemic stroke. However, today there are no 
strategies to prevent ischemic stroke in cancer survivors.
 The co-occurrence of stroke and head and neck cancer and cancer in general seems to be 
partly related to shared preventable vascular risk factors. Therefore, we developed a onetime 
screening and treatment of vascular risk factors in patients with head and neck cancer treated 
with radiotherapy. A computer simulation model showed that a strategy consisting of a 
onetime screening and treatment of vascular risk factors was not cost-effective over a 
long-term period. However, in this computer model we had to make several of estimates and 
assumptions for parameters such as risk of stroke, costs of stroke and obtained relative risk 
reduction by the strategy. The added value of this model are the sensitivity analysis that 
estimate the change in cost effectiveness with changes in costs of stroke, costs of the 
prevention strategy and the relative risk reduction of stroke. The model we used was conser-
vative. First, we only took into account the direct health costs and not the costs associated 
with unemployment after stroke. Second, vascular risk reduction in this group of patients with 
a burden of modifiable vascular risk factors probably will not only prevent strokes, but also 
other vascular diseases (acute myocardial infarction and peripheral arterial disease), COPD, 
diabetes and recurrent cancer. The sensitivity analysis suggests that, if we would take these 
not directly visible costs and additional risk reductions into account as well, it could be cost 
effective. Furthermore, more follow-up visits instead of a one-stop strategy are needed to 
increase patient’s adherence to the prevention strategy. The current model and the results of 
the sensitivity analysis can be a guide in the development of future clinical trials assessing 
prevention strategies of vascular risk factors in specific groups of cancer survivors.
GENERAL DISCUSSION
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METHODOLOGICAL CONSIDERATIONS
STUDY DESIGN
The studies described in this thesis are based on patient cohorts. We observed relationships 
with a prospective, cross-sectional and retrospective view. To study changes in carotid intima 
media thickness and stroke risk in head and neck cancer patients over a longer time, we used 
a prospective study design. To assess cognition and MRI changes in this study cohort, we used 
a cross sectional design, because baseline assessments were not available. This design 
prevented us from studying changes in these parameters over time and hence from making 
causal inferences about the effect of radiotherapy.
 From the perspective of an efficient and feasible design we studied prevalence of cancer 
in stroke patients to assess long-term effect of cancer. The drawback of such an approach is 
effects of selective survival and the inability to assess absolute risks. A known disadvantage 
of computer modeled cost-effectiveness studies is the assumptions that have to be made, 
resulting in crude estimations of the real world.
VALIDITY
The internal validity of our results could have been threatened by selection bias. Selective 
follow-up results in a cohort of relatively motivated and mobile patients with a potential 
underestimation of the effect in the cohort study of head and neck cancer patients and in the 
stroke cohort. A second form of selection bias, called referral bias, could have resulted in an 
overestimation of stroke in cancer survivors in the PSI study, because only patients presenting 
in university medical centers were included. We do not think that information or confounding 
bias played an important role, because the endpoints were objective (potentially few variation 
in measurements) and there were no variables that were related to both the radiotherapy 
and the endpoint of stroke. The external validity or generalizability is warranted, because 
there are no major in or exclusion criteria in our studies and given the way head and neck 
cancer treatment is organized in the Netherlands (centralized in dedicated cancer centers).
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The results described in the prospective cohort study in HNC patients treated with RT, cannot 
be generalized to whole population of HNC patients. The patients included in our study were 
only treated with surgery and RT, because of limited local disease. In contrast, in HNC patients 
with more advanced disease, chemoradiation, including cisplatin is standard of care. In the 
group of advanced HNC patients, the incidence of stroke could be higher than in the patients 
treated with RT alone, because cisplatin is a known risk factor for thromboembolic events. 116 
Cisplatin associated vascular complications are beyond the scope of this thesis. We focused 
on the etiology of RT induced vasculopathy, which typically is a long-term complication. 
Therefore we included only HNC patients with limited local disease, who have a relative good 
long-term prognosis making them prone to the long-term vascular complications. Hence, we 
were not able to study the potential interaction between RT and cisplatin chemotherapy in 
relation to long-term vascular complications.
PRECISION
The relatively small sample size is a limitation of the prospective cohort study in head and 
neck cancer patients. The reproducibility of the ultrasound measurements would be optimized 
when the study cohort was larger and the measurements were more repeated and done in 
one center by one person. Therefore, non-differential misclassification could have played a 
role. Using a dedicated neck coil and contrast enhanced pictures could increase the distinctive 
character of the MRI measurements.
CLINICAL RELEVANCE
Since the group of cancer survivors increases, it is clinically relevant to define which types of 
cancer are particularly associated with an increased risk of stroke. Strategies to prevent 
vascular complications in cancer patients are lacking. The studies described in this thesis can 
be helpful in developing strategies to prevent vascular disease in patients with cancer. Rigorous 
treatment of vascular risk factors in patients with cancer can be a potential prevention strategy 
for vascular diseases and probably increases survival rates. Prevention of ischemic stroke and 
other vascular diseases in cancer patients means prevention of disability due to these diseases 
and its associated social handicaps, like unemployment and social isolation. Patients have to 
be informed of these potential long-term complications of the radiotherapy.
METHODOLOGICAL CONSIDERATIONS
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FUTURE DIRECTIONS
CASE CONTROL STUDY IN LONG-TERM HEAD AND NECK CANCER SURVIVORS
A limitation of the studies described in this thesis is the relatively short follow-up period of 
seven years and the small number of included patients. To assess long-term radiotherapy 
induced vasculopathy in head and neck cancer patients, longer follow-up and consequently 
more obvious pathologic vascular changes are preferable. To study imaging characteristics of 
radiotherapy induced vasculopathy, a case control study in head and neck cancer patients 
treated with radiotherapy at least ten years before would be helpful. When patients will be 
included with only unilateral radiotherapy, it is possible to perform an in-patients control and 
the vascular changes in the irradiated side can be compared to the vascular changes in the 
non-irradiated side. Advanced MRI techniques with contrast enhanced imaging and the use 
of dedicated neck coils could enable more detailed plaque analysis. Ideally these imaging 
studies are combined with histologic verification of autopsy material. This can help us to 
answer the question if this radiotherapy-induced vasculopathy is different from “common” 
atherosclerosis. And hence should possible be treated with a different prevention paradigm.
 The most obvious prevention strategy to prevent radiotherapy-induced vasculopathy would 
be to block the carotid arteries out of the radiotherapy portal. However, to date and in the 
near future this is not feasible, because the anatomic location of the carotid artery is nearby 
the tumor sites of the nasopharynx, larynx and parotids. However, dose reduction would 
probably be helpful, but only when it is not accompanied by tumor recurrence rate. An ongoing 
study assesses the effect of dose reduction on tumor control in elective head and neck cancer 
patients.115 A side study to assess the carotid wall changes in the group with dose reduction 
and the group with the maximal dose could be helpful, but long follow-up time is needed.
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PREVENTION OF VASCULAR DISEASE IN HNC PATIENTS (PREVASC);
PROSPECTIVE RANDOMIZED OPEN BLINDED ENDPOINT TRIAL
This thesis showed the co-occurrence of stroke and cancer, in particular ischemic stroke in 
head and neck cancer patients. Future preventive strategies to prevent vascular disease in 
cancer survivors have to be developed, studied and implemented in the standard of care. The 
increased risk of ischemic stroke in head and neck cancer patients can be explained by 
long-term radiotherapy induced atherosclerosis, but is likely also for a large part caused by 
preventable vascular risk factors.
 We propose a prospective randomized open blinded endpoint (PROBE design) trial to assess 
the effectiveness of an outpatient clinic prevention strategy called PREvention of VAScular 
disease in Cancer (PREVASC) in head and neck cancer patients. HNC patients 1-3 years after 
successful completion of curative radiotherapy, either alone or in combination with surgery 
and/or chemotherapy will be included. PREVASC will be compared to care as usual. PREVASC 
consists of daily aspirin in combination with screening, counselling and treatment of vascular 
risk factors at 3 months, annually until 5 years and at 10 years. The protocol is based on the 
multidisciplinary cardiovascular risk management guideline from the Dutch society of general 
practitioners and internal medicine.101,102 The result is a structured and evidence-based 
personal advice to treat vascular risk factors and change lifestyle. The primary endpoint is the 
composite of death from all vascular causes, non-fatal stroke, non-fatal myocardial infarction 
or major bleeding complication, whichever occurs first. Secondary endpoints are ischemic 
stroke, secondary cancer and mortality. Follow-up with structured interview by mailed form 
will be at 6 months, annually until 5 years and after 10 years.
 Compared with the cost-effectiveness study described in this thesis, we think improving 
the compliance rate of patients by a yearly outpatient refresh visit will ameliorate the effect 
of the PREVASC. Furthermore, the current prevention strategy will not only prevent ischemic 
stroke, but also other vascular diseases and probably also improves cancer survival rates and 
prevents second cancers.
 This trial would be the first to assess the effectiveness of a prevention strategy of ischemic 
stroke in cancer patients. The results of this study could be used as a starting point for 
prevention strategies in other cancer types using the PREVASC program as a template.
In the current era, cancer treatment should not only be aimed at cancer, but also at the 
prevention of its long-term complications, including stroke.
FUTURE DIRECTIONS
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NEDERLANDSE SAMENVATTING
Verbeterde anti-kanker therapie heeft resultaat geboekt. De laatste 10 jaar overleeft een 
steeds groter wordende groep mensen kanker. Na een periode van ernstige ziekte, zware 
behandelingen, bijwerkingen en onzekerheid is er genezing. Deze langere overleving gaat 
echter deels gepaard met invaliderende lange termijn complicaties. Een van deze gevolgen is 
de kans op hart- en vaatziekten.
 Dit proefschrift beschrijft de karakteristieken van lange-termijn neurovasculaire complicaties 
bij hoofd-halskanker-patiënten en kankerpatiënten in zijn algemeenheid. Patiënten met 
hoofd-halskanker (met name keelkanker) behandeld met bestraling van de halsregio hebben 
een verhoogd risico op schade van de halsslagaders en daaraan gerelateerde herseninfarcten 
als gevolg van de bestraling. Deel 1 van dit proefschrift beschrijft de karakteristieken en 
gevolgen van deze door radiotherapie veroorzaakte vaatschade bij patiënten met 
hoofd-halskanker.
 Kanker en hart- en vaatziekten zijn de twee meest voorkomende dodelijke aandoeningen 
wereldwijd. Bij 15% van de patiënten met kanker wordt bij autopsie aanwijzingen voor 
vaatschade in de hersenen gevonden. Het samen voorkomen van deze twee aandoeningen 
kan berusten op toeval, omdat beide aandoeningen veel voorkomen in de algemene bevolking, 
maar het kan deels ook het gevolg zijn van geassocieerde risicofactoren (zoals roken), directe 
kanker-effecten (zoals verhoogde stollingsneiging) of de lange-termijn gevolgen van de 
anti-kanker therapie (bijwerking van radiotherapie of chemotherapie). Deel 2 van dit 
proefschrift beschrijft de prevalentie en karakteristieken van kanker in een cohort van 2,736 
patiënten die zich presenteren met een herseninfarct of TIA. Het uiteindelijke doel is het 
voorkomen van vaatschade en herseninfarcten bij hoofd-halskanker patiënten.
 Deel 3 beschrijft de kosteneffectiviteit van het vroegtijdig opsporen en behandelen van 
risicofactoren voor hart- en vaatzieken bij patiënten met hoofd-halskanker.
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De belangrijkste conclusies van dit proefschrift zijn:
1. Bij patiënten met hoofd-halskanker behandeld met bestraling is:
1.1. Er geen verdikking van de halsslagader, gemeten met echo, twee jaar na 
radiotherapie.
1.2. Er een verdikking van de halsslagader, gemeten met echo, zeven jaar na 
radiotherapie.
1.3. Er een meer verdikte wand van de bestraalde halsslagader, gemeten met echo, 
dan de niet bestraalde halsslagader, zeven jaar na radiotherapie, maar er is geen 
verschil in MRI signaal van de vaatwand.
1.4. De incidentie van herseninfarcten hoger dan in de algemene populatie zeven jaar 
na radiotherapie (ongeveer zes keer verhoogd).
1.5. Cognitief functioneren is slechter in vergelijking met de algemene populatie zeven 
jaar na radiotherapie.
1.6. Cognitief functioneren geassocieerd met subjectieve cognitieve klachten, 
vermoeidheid en herseninfarcten op de MRI, echter niet met depressieve 
klachten, de aanwezigheid van vasculaire witte stofafwijkingen of hersenatrofie op 
de MRI.
2. De prevalentie van kanker bij patiënten met een herseninfarct in Nederland is 12%; dit 
is ongeveer 20% meer dan in de algemene populatie.
3. Patiënten met een herseninfarct hebben in vergelijking met de algemene populatie een 
toegenomen gestandaardiseerde prevalentie ratio voor kanker en in het bijzonder voor 
centraal zenuwstelsel-, hoofd-hals-, luchtweg- en blaaskanker.
4. Een eenmalige screening en behandeling van vasculaire risicofactoren bij nieuw 
gediagnosticeerde patiënten met hoofd-halskanker is niet kosteneffectief.
In de toekomst moet de behandeling van patiënten met kanker niet alleen gericht zijn op 
genezing van de kanker, maar ook rekening houden met preventie van lange-termijn compli-
caties, zoals herseninfarcten.
NEDERLANDSE SAMENVATTING
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